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BAG-1 OVEREXPRESSION LEADS TO BAD PHOSPHORYLATION AT 
SERINE 136 REVEALING A ROUTE FOR SURVIVAL IN MCF-7 BREAST 
CANCER CELL LINE 
SUMMARY 
Bcl-2 associated athanogene family (athano = against death in Greek) proteins are 
discovered by co-immunoprecipitation with Bcl-2 anti-apoptotic protein. Bag genes 
are evolutionally conserved and their homologes exist in yeasts, plants and animals. 
Bag family members control the cell homeostais in two different ways: (1) They 
contribute to maintain cell’s vital activity under normal and stress conditions via 
regulating both positively and negatively the cycle of Hsp70/Hsc70 molecular 
chaperone system. For instance, the direction of the cell balance under normal and 
stress conditions are maintained by competitive binding of Hsp70 or Raf-1 to Bag-1. 
(2) They form complexes with transcription factors and nuclear hormone receptors, 
which are controlling various physiological processes such as apoptosis, 
tumorigenesis, neural differentiation and cell cycle independent from Hsp70/Hsc70 
system. 
Bag-1 isoforms are produced by the alternative translation initiation of single mRNA 
transcript; thereby they differ in their N-terminus related to translation initiation. 
Bag-1 isoforms appear to be differently localized in the cells. Main Bag-1 isoforms 
which are observed in humans are Bag-1S (36 kDa), Bag-1M (46 kDa) and Bag-1L 
(50 kDa). There is also another isoform of Bag-1, 29 kDa, however, it is very scarce 
in the cell, and thus is not consistently detected.  
All of Bag-1 isoforms commonly contain both the ubiquitin-like domain (ULD) and 
Bag domain (BD) in their C-terminus. Even though ULD domain function is not 
clearly known, its evolutionary conservation and its relations with proteosome 
machinery indicate that ULD is necessary for stress tolerance. Bag-1L is localized in 
nucleus by means of its nuclear localization signal (NLS). NLS does not exist in 
Bag-1M, which is known to be cytosolic but some studies revealed Bag-1M 
translocation to nucleus via companion proteins, Bag-1S, on the other hand, always 
presents in cytosol. N-terminus of Bag-1L and Bag-1M consist of eight TXSEEX 
repeats. It is shown that these repeats have a role in DNA binding and transcription 
activation depending on their nuclear localizations. Having less repeat sequences, 
Bag-1S is the shortest isoform in the cells. 
Bag-1 has many critical roles in the cell through its interactions with certain target 
molecules to regulate carcinogenesis, differentiation, motility, proliferation, cell 
survival, apoptosis and transcription. Nuclear hormone receptors, Siah, CHIP, HGF 
receptor, Hsp70/Hsc70 complex, Bcl-2, and C-Raf (Raf-1) are known interacting 
partners of Bag-1. Cell survival and apoptosis are the two major pathways that Bag-1 
is involved in. Bag-1 interactions with C-Raf or Bcl-2 are main mechanism that 
determine cell fate. Through these interactions Bag-1 gets invoved in the regulation 
the balance between cell death and cell survival. Although Bag-1 involvement in 
xviii 
 
different mechanisms is known, the molecular details of these mechanisms and 
crosstalk between the pathways are not clear yet. 
In this study, we aimed to elucidate the molecular mechanism of Bag-1-associated 
cell survival in MCF-7 breast cancer cell line. To understand Bag-1’s influence on 
cell survival, we altered expression levels of Bag-1 in MCF-7 cells. TAP tagged-
Bag-1 overexpressing plasmid was used for enhencement of Bag-1 level, and Bag-1 
specific siRNA transfection was applied for down regulation of Bag-1. XTT cell 
proliferation assay and tryphan blue dye exclusion assay were performed to explain 
Bag-1’s effect on cellular level. Western blot analysis was used for checking 
expression levels of proteins that take part in cell survival and signaling pathways to 
investigate changes in the expression after Bag-1 overexpression or silencing. To 
deduce molecular details of Bag-1-related cell survival we checked interaction 
partners of Bag-1 during cell survival using co-immunoprecipitation. We also did 
immunocytochemistry to demonstrate subcellular co-localization of Bag-1 with its 
interaction partners from the cell survival complex. Our results showed that C-Raf is 
involved in the complex that is formed by B-Raf, Hsp70, phospho-Akt and Bcl-2 in 
order to phosphorylate Bad at serine 136 residue for the prevention of apoptosis. 
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BAG-1’İN AŞIRI İFADESİ BAD SERİN 136 FOSFORLANMASINI 
SAĞLAYARAK MCF-7 MEME KANSERİ HÜCRE HATTINDA 
SAĞKALIMI İŞARET EDER 
ÖZET 
Bcl-2 asosiye athano gen (Bag) ailesi (Yunanca ölüm karşıtı athanostan) proteinleri 
anti-apoptotik Bcl-2 proteini ile ko-immunopresipitasyon sonucu bulunmuşlardır. 
Bag genleri evrimsel olarak korunmuştur ve mayalarda, bitkilerde ve hayvanlarda 
homologları mevcuttur. Bag ailesi üyeleri iki farklı yolla hücre homeostazını kontrol 
eder: (1) Hem pozitif hem negatif şekilde Hsp70/Hsc70 moleküler şaperon 
sisteminin çalışma döngüsünü regüle ederek hücrenin yaşamsal faaliyetlerini normal 
ve stres koşullarında sürdürmesine katkıda bulunur. Buna spesifik bir örnek, 
hücrenin normal ve stres halleri arasındaki dengesinin yönünün Bag-1’e Hsp70 ya da 
Raf-1’in yarışmalı bağlanması sonucu sağlanması ile verilebilir. (2) Apoptoz, tümör 
oluşumu, nöronal farklılaşma ve hücre döngüsü gibi birçok fizyolojik süreci kontrol 
eden transkripsiyon faktörleri ve reseptörler ile Hsp70/Hsc70 sisteminden bağımsız 
olarak kompleksler oluşturur.  
Bag ailesi üyelerinin, insanlarda, kanser, AIDS ve Parkinson gibi kompleks 
hastalıklarda normal hücrelere kıyasla ekspresyon düzeylerinde ve hücre içi 
lokalizasyonlarında değişiklikler gözlenmektedir. Dolayısıyla, bu tip hastalıkları 
tahlil etmede Bag proteinlerinin hücre içi ekspresyonlarını ve lokalizasyonlarını 
incelemeye yönelik çalışmalardan yararlanılabilir. Örneğin, kanserli meme 
hücrelerinde yapılan çalışmalarla Bag-1 ekspresyonunun, hastalığın seyrinin 
izlenmesinde prognostik bir markör olarak kullanılabileceği gösterilmiştir. 
Belirlenmiş Bag proteinleri Bag-1 (RAP46/HAP46), Bag-2, Bag-3 (CAIR-1/Bis), 
Bag-4 (SODD), Bag-5 ve Bag-6 (BAT3/Scythe) olup hepsi C-terminus yakınında 
BAG domen (BD) ifadesine sahiptir. Bag proteinlerinin genellikle N terminuslarında 
farklılık göstermesi her bir Bag ailesi üyesinin çeşitli proteinler, yolaklar ve/veya 
lokalizasyonlara göre spesifite göstermesini sağlar. Hücrelerde Bag-1 izoformlarinin 
ekspresyon düzeyleri farklılık göstermektedir. Bu izoformlar hücrelerde bulunma 
sıklıklarına göre Bag-1S, Bag-1L ve Bag-1M olarak sıralanabilir. Buna rağmen 
tümörlü hücrelerde ekspresyon düzeyi en yüksek olan Bag-1L izoformudur. Bunun 
nedeni ise Bag-1L’nin nüklear lokalizasyonuna bağlı olarak transkripsiyon 
faktörlerinin aktivitesini yönlendirmesi ve böylece hücre proliferasyonunu dolaylı 
yoldan tetiklemesi olabilir. 
Bag-1 izoformlarının hücrelerde daha önce yapılmış çalışmalar sonucu belirlenmiş 
etkileşim partnerleri; Bcl-2, Raf-1, Hsc70/Hsp70 sistemi, nükleer hormon 
reseptörleri (NHR), ubikuitin/proteozom mekanizması ve DNA'dır. Bu etkileşimlerle 
Bag-1 izoformları, hücre büyümesi için kritik sinyal iletimi, proliferasyon, 
transkripsiyon gibi hücresel mekanizmalardan, hücre hareketi ve apoptoza varana 
kadar normal, malignan ve stres altında bulunan hücreler için önemli kontrol 
yolaklarında görev almaktadır. Bag-1 izoformlarinin belirtilmiş olan geniş 
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perspektifli bu hücresel aktiviteleri genel olarak Bag ailesi üyeleri için tanımlandığı 
gibi iki farklı şekilde kontrol ettiği literatürde yer almaktadır: (1) Hsp70/Hsc70 
sistemi ile etkileşim yoluyla, (2) nüklear hormon reseptörlerine (NHR) 
bağlanmasıyla. 
Bag-1 izoformlarinin Hsp70/Hsc70 moleküler şaperon sistemi ile etkileşiminde BAG 
domenleri Hsc70’in ATPaz domeninine bağlanır, konformasyonel değişiklikler 
yaratarak ADP’nin ATP ile değişimine etkide bulunur ve sonuçta bu şaperonların 
peptit bağlayan domenlerinin substrat proteinleri ile olan bağlanma/ayrılma 
kinetiklerini regüle eder. Bu şekilde bozunmuş hedef proteinin yeniden katlanıp 
katlanmayacağı kontrol edilmiş olur.  
Bag-1 izoformları, Hsp70/Hsc70 sistemini hem pozitif hem de negatif yönde kontrol 
ederek sırasıyla hücrelerin efektif bir şekilde protein üretebilmesi sonucu hücre 
büyümesine ya da hücrelerin protein üretiminin yavaşlaması sonucu hücre ölümüne 
yol açabilir. Fakat bu kritik ayarlamada, henüz Bag-1’lerin Hsp70/Hsc70 sistemine 
tam olarak moleküler düzeyde nasıl bir kontrol mekanizması ile etkide bulunduğu net 
olarak bilinmemektedir. Şu ana kadar yapılmış bu konudaki çalışmalar tutarsız 
sonuçlar ortaya koymaktadır. Bazı çalışmalar Bag-1M’nin Hsp70/Hsc70 sistemine 
bağlanması sonucu oluşan konformasyonel değişikliğin ADP’nin ATP ile değişimine 
imkan vermeyerek protein katlanmasını engelleyici özellik gösterdiği yönündedir. 
Bunun yanı sıra, bir çalışmada Bag-1S’nin protein katlanmasına pozitif yönde bir 
etki göstermesine karşın daha sonra yapılan bir çalışmayla negatif yönde bir etkide 
bulunduğu ortaya çıkartılmıştır. Bu konudaki belirsizlikler, Bag-1 izoformlarının 
Hsp70/Hsc70 sistemi üzerinden hücre yaşamındaki etkilerinin anlaşılmasını 
güçleştirmektedir. Bu durumla ilgili çeşitli hipotezler ortaya atılmış ve bunları 
destekleyici bazı sonuçlara ulaşılmıştır. Kritik yolakların aydınlatılması yolunda 
literatürde yer alan örnekler aşağıda özetlenmektedir. 
Bag-1’in Hsc70 ile etkileşimi sonucu Bcl-2 ile bir kompleks oluşturduğu 
gözlemlenmiştir. Anti-apoptotik Bcl-2 ile Bag-1’in etkileşimi, öncelikle Bag-1’in C-
Raf (Raf-1) serin/treonin kinazı ile kompleks oluşturması sonucu gerçekleşir. Bunun 
sonucunda hücrenin yaşam ya da ölüm kaderini belirleyecek etkileşimlerin 
tetiklendiği ortaya çıkartılmıştır. Bag-1/C-Raf kompleksinin apoptoz öncüsü Bad 
(pro-apoptotik) proteinini fosforilasyonu sonucu, halihazırda hücrede bulunan Bcl-
2’nin anti-apoptotik etkisini baskılayan Bcl-2/Bad etkileşimlerinin bozulabileceği ve 
böylelikle Bcl-2’lerin serbest kalarak apoptoz öncüsü Bax’in dimer oluşturmasını 
engellemesiyle hücrenin yaşamasının sağlandığı düşünülmektedir.  
Bu çalışmayla amaçlanan, MCF-7 meme kanseri hücre hattında Bag-1-ilişkili 
sağkalım mekanizmasının moleküler detaylarının aydınlatılmasıdır. Bu amaç 
doğrultusunda Bag-1’in ekspresyon seviyeleri değiştirilmiş ve hücreye etkisi 
incelenmiştir. Bag-1’in aşırı ekspesyonunu sağlama amacı ile TAP-tag içeren Bag-
1’in ekspresyonunu arttıran plazmit; Bag-1’i susturmak için ise Bag-1’e özgü siRNA 
kullanılmıştır. Bag-1’in ekspesyonundaki değişikler western blotlama ile 
doğrulanmıştır. Bag-1’in aşırı ifadesinin hücre canlılığına yaptığı pozitif etkiler XTT 
hücre canlılığı ve tripan mavisi sağkalım deneyleri ile gösterilmiştir. Bag-1’in aşırı 
ifadesinin MCF-7 meme kanseri hücrelerinde sağkalımı arttırdığı gösterildikten 
sonra sağkalım yolağında görev yapan proteinlerin ekspresyonunun Bag-1 
ekspresynundaki değişimlerle birlikte nasıl etkilendiği western blotlama ile 
araştırılmıştır. Western blot analizi sonuçları önemli MAP (mitogen-activated 
protein) kinazlar olan B-Raf ve C-Raf ekpresyonlarının Bag-1 aşırı ifadesi ile 
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arrtığını göstermiştir. Ayrıca B-Raf’ın Serin 445, C-Raf’ın Serin 338 ve 
289/296/301, Akt’nin Serin 473 bakiyelerinden fosfoslanma seviyelerinin ve Hsp70 
expresyonunun da Bag-1 aşırı ekspesyonu ile arttığı, Bag-1’in susturulması ile 
azaldığı da western blotlama ile gözlemlenmiştir. Bag-1’ın hücre sağkalımını 
tetiklediği gösterildikten sonra Raf-Erk-MEK sinyal yolağının alt akışında bulunan 
proteinlerin de (Erk ve MEK) ekspresyonunu arttırdığı gösterilmiştir. 
Östrojen bağımlı meme kanseri hücrelerinde Bag-1’in bu sağkalım kompleksindeki 
etkileşim partnerlerini incelemek için ko-immünopresipitasyon yapılmıştır. Bag-1, 
fosforlanmış Akt, B-Raf, C-Raf,  Bcl-2 ve Hsp70’in oluşturduğu bir kompleksin 
hücrede sağkalım mekanizmasını tetiklediği gösterilmiştir. Bag-1’in hücre içinde 
forforlanmış Akt, B-Raf, Bcl-2, Hsp70 ve C-Raf ile birlikte lokalize olduğu immüno 
hücre boyaması ile ispatlanmıştır. Daha önce sinir hücreleri (birincil hücre hattı) ile 
yapılan bir çalışmada Bag-1-ilişkili sağkalım kompleksine C-Raf’ın dahil olmadığı 
bulunmuştur.  
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1.  INTRODUCTION 
1.1. Bag-1 gene and isoforms 
Bag-1 (Bcl-2 associated athanogene gene)  is located on human chromosome 9, band 
12 and it encodes 3885 bp mRNA having 7 exons (Takayama et.al, 1995). The 
promoter has been dispersed along the positions -353 to -54 upstream of the first 
translational start codon and is a binding site for several transcription factors 
(Takayama et al., 2005). 
There are multiple translation start sites on the nucleotide sequence of Bag-1 (Zheng 
et al., 2010). The first translation is started on mRNA sequence, at 66th codon 
(CUG) to encode Bag-1L (Zheng et al., 2010). Bag-1M is initiated from 279th codon 
(AUG), Bag-1S and Bag-1 are encoded from 411st and 504th amino acids, 
respectively (Zheng et al., 2010) (Figure 1.1). Even though alternative translation 
mechanism is not yet clear, there are hypothesis that might explain for the 
mechanism of translation (Townsend et al., 2005). While Bag-1L and Bag-1M 
isoforms are translated via of 5’ cap structure of Bag-1 mRNA (Coldwell et al., 
2001), Bag-1S isoform translation is dependent on an internal ribosome entry site 
(IRES). The ribosome binds to IRES element of the mRNA (Dobbyn et al., 2008).  
According to these translation start sequences, ribosomes can settle on one of three 
certain sites diversely (Gehring et al., 2006). This selection of the site produces 
differential protein isoforms expression for Bag-1 (Gehring et al., 2006). The longest 
Bag-1 isoform is Bag-1L (50 kDa), and the others are Bag-1M/Rap46 (46 kDa), and 
Bag-1S (36 kDa) in human cells (Gehring et al., 2006). There is also another isoform 
of Bag-1, 29 kDa, however, it is very scarce in the cell and due to that is not 
consistently detected (Gehring et al., 2006).  
Subcellular localization of Bag-1 isoforms is important for different biological 
mechanisms (Knee et al., 2001). The NLS (nuclear localisation signal or nuclear 
localisation sequence) domain of Bag-1 mRNA is responsible for nuclear 
localization of Bag-1L (Knee et al., 2001). Bag-1M has both nuclear and cytosolic 
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fractions of NLS according to the initiation site of translation of the mRNA 
(Brimmell et al., 1999). However, the localization of Bag-1 isoforms can be 
regulated by cellular stress conditions which can cause relocalization of Bag-1S and 
Bag-1M to the nucleus (Townsend et al., 2002). 
These isoforms have different impacts on heat shock protein function, ubiqutination 
and different transcriptional activities (Liu et al., 2009). C- terminal “Bag  domain” 
is found in all members of Bag protein family. Bag domain was first described as a 
conserved region which has about 50 amino acids (Takayama et al., 1999), but recent 
studies with advanced techniques like X-ray crystallograpghy, and multidimensional 
nuclear magnetic resonance (NMR) revealed that Bag-1 domain has 110-124 amino 
acids and it consists of three anti-parallel α-helices, each approximately 30-40 amino 
acids in length (Briknarova et al., 2001; Sondermann et al., 2001). These helices 
provide interaction sites for other proteins; the first and second helices (α-1 and α-2) 
interact with the serine/threonine kinase Raf-1 and the second and third helices (α-2 
and α-3) are the sites of interaction with the ATPase domain of Hsc70/Hsp70 
(Takayama at al., 2001; Sondermann et al., 2001; Song et al., 2001) and TNF-R1 
(Antoku et al., 2001).  
All three isoforms of Bag-1 has a ubiquitin- like domain (ULD) (Bricknarova et al., 
2001). Ubiquitin is a ubiquitous 76 amino acid protein that is covalently attached to 
protein substrates to target proteins for degradation by proteosome, the major non-
lysosomal proteolytic complex in cells (Pickard et al., 2001). Bag-1 has been shown 
to be ubiquitylated, but Bag-1 proteins have relatively long half-lifes (Luders et al., 
2000). Therefore Bag-1 may play a role in coordinating ubiquitin system instead of 
participating in conjugation reactions (Townsend et al., 2003). Although the ULD of 
Bag-1 is structurally related to ubiquitin, Bag-1 is not covalently attached to protein 
substrates. The ULD is essential for some but not all biologic functions of Bag-1, and 
does appear to be significant for binding to the proteasome (Townsend et al., 2005).  
Although Bag-1 predominantly functions to suppress apoptosis, most likely acting 
between the growth/survival receptors and the mitochondria, it also involves other 
regulatory points in the apoptotic cascade (Takayama et al., 2001). Bag-1 interacts 
with the ATPase domain of Hsc70, and Hsc70 may play a role intermediumte in the 
binding of Bag-1 to Bcl-2 (Cutress et al., 2003). Heat shock proteins such as Hsp70 
and Hsc70, play an essantial role in assembly of multimeric apoptosis regulating 
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complex “apoptosome” via their charcteristic “chaperone” function (Townsend et al, 
2003). Since Bag-1 directly binds to Hsp70/Hsc70, and regulates their activities by 
acting as a nucleotide exchange factor, it can be named as a “co-chaperone” (Nollen 
et al., 2000). It has been reported that in MCF-7 cells with a mutation of a single 
residue in the Bag domain of Bag-1S heat shock protein binding can be prevented, 
but this mutation did not affect C-Raf (Raf-1) interaction. Also, through this 
mutation, Bag-1’s protecting ability for heat shock-induced growth inhibition was 
prevented (Townsend et al., 2003). It has been demonstrated that at least in an 
artificial in vitro system, Bag-1M could interact with a wide range of proteins 
including c-Jun, c-Fos, c-Myc and Mos, which are important for the regulation of 
cell cycle (Zeiner et el., 1997).  
 
Figure 1.1 : Schematic presentation of Bag-1 mRNA. Alternative translation sites of 
Bag-1 mRNA (A). Bag-1 isoforms with the binding domains (B) 
(Zheng et al., 2010). 
1.2 Apoptosis 
Cell death is important to maintain cell population, especially during the 
developmental stages of both animals and plants (Alberts et al., 2008). Maintenance 
of the balance between cell division and tissue volume is provided by a process 
known as programmed cell death which usually occurs by apoptosis (“falling of” in 
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Greek) (Alberts et al., 2008). Apoptosis causes a wide range of morphological 
changes; cells shrink and condense, the cytoskeleton collapses, the nuclear envelope 
disassembles, and the chromatin condenses and breaks up into fragments (Alberts et 
al., 2008) (Figure 1.2). 
 
Figure 1.2 : The electron micrographs of apoptotic cells. The cell that died in a   
culture dish (A), died in developing tissue and engulfed by a 
phagocytic cell (B) (Alberts et al., 2008). 
To understand the apoptotic morphology, including the early process of apoptosis, 
cell shrinkage and pyknosis can be monitored by light microscopy (Kerr et al., 1972). 
At the end of cell shrinkage, cells become smaller in size, the cytoplasm denses and 
the organelles become more tightly packed (Kerr et al., 1972). Pyknosis, also known 
as irreversible condensation of chromatin, is the most characteristic feature of 
apoptosis (Savill and Fadok, 2000). Extensive plasma membrane blebbing occurs 
after separation of cell fragments into apoptotic bodies, which is an indicator of late 
apoptosis, during a process called “budding” (Savill and Fadok, 2000). Apoptotic 
bodies, which include tightly packed organelles with or without nuclear fragment, are 
subsequently phagocytosed by macrophages, paranchymal cells, or neoplastic cells, 
and finally degraded within phagolysosome (Savill and Fadok, 2000). Tingible body 
macrophages which are responsible for the elimination of apoptotic cells engulf and 
digest apoptotic cells, and there is essentially no inflammatory reaction related 
neither with the process of apoptosis, nor with the removal of apoptotic cells (Savill 
and Fadok, 2000). Because: (1) apoptotic cells do not exudate their cellular 
components into surrounding interstitial tissue; (2) they are fastly phagocytosed by 
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surrounding cells; and (3) the engulfing cells do not produce anti-inflammatory 
cytokines (Savill and Fadok, 2000). 
Apoptosis could be both a normal event or a response to a certain stimuli (Norbury 
and Hickson, 2001). Apoptosis takes place during development and aging and as a 
homeostatic mechanism to control cell population in tissues (Norbury and Hickson, 
2001). Apoptosis also occurs as a defence mechanism in immune reactions (Norbury 
and Hickson, 2001). 
1.2.1 Apoptotic pathways 
The mechanisms of apoptosis are very complicated and sophisticated, involving an 
energy dependent cascade of caspases, however researchers were able to clasify the 
mechanisms of apoptosis into two major pathways (Elmore, 2007). They are (1) the 
extrinsic or death receptor pathway and (2) the intrinsic or mitochondrial pathway. 
Those two pathways are linked and that molecules in one pathway can affect the 
other (Igney and Krammer, 2002). There is an additional pathway, which can induce 
apoptosis via either granzyme A or granzyme B, and includes T-cell mediumted 
cytotoxicity, called as “perforin/granzyme pathway” (Igney and Krammer, 2002). All 
of these three pathways meet on the same termination point or in other words 
execution pathway (Igney and Krammer, 2002) (Figure 1.3). 
Extrinsic pathways are related with the transmembrane receptor-mediumted 
interactions which involve death receptors that are members of the tumor necrosis 
factor (TNF) receptor gene superfamily, and they share similar cyteine-rich 
extracellular domains and have a cytoplasm domain of about 80 amino acids called 
the “death domain” (Locksley et al., 2001). Extrinsic phase of apoptosis is best 
characterized with the FasL/FasR and TNF-α/TNFR1 models, in which clustering of 
receptors and binding with the homologous trimeric ligand occur (Hsu et al., 1995). 
Cytoplasmic adaptor proteins, FADD (Fas-associated death domain) and TRADD 
are needed to transmit the death signal after getting activated by their receptors. 
FADD protein activation through Fas ligand binding to Fas receptor enables initiator 
caspase activation (Hsu et al., 1995). TRADD protein can also get activated and 
relay death signals with the recruiment of FADD and RIP by activation through 
binding of TNF ligand to TNF receptor (Hsu et al., 1995; Wajant, 2002). FADD then 
associates with procaspase-8 with the help of the dimerization of death effector 
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domain, and it results with the formation of death-inducing signalling complex 
(DISC), initiating the auto-catalytic activation of procaspase-8 (Kischkel et al., 
1995). 
Intrinsic pathways include a wide range of non-receptor mediumted stimuli (Garrido 
et al., 2006). Opening of the mitochondrial permeability transition (MPT) pore, loss 
of the mitochondrial transmembrane potential and release of cytocrome c, 
Smac/DIABLO, and the serine protease HtrA2/Omi into cytosol are the results of 
alterations in the inner mitochondrial membrane caused by stimuli such as radiation, 
hypoxia, viral infections, free radicals and loss of growth factors, hormones or 
cytokines that can lead to failure of cell death suppression thereby triggering the 
apoptosis (Garrido et al., 2006). Those proteins initiate the caspase dependent 
mitochondrial pathway. As a result of cytchrome c binding and activation Apaf-1 as 
well as procaspase-9, an “apoptosome” is formed (Chinnaiyan, 1999; Hill et al., 
2004). 
Cytotoxic T lymphocytes (CTLs) are able to kill target via extrinsic pathway, but 
they are also able to exert their cytotoxic effects on tumor cells or virus-infected cells 
via a novel pathway that involves secretion of the transmembrane pore-forming 
molecule perforin with a subsequent exophytic release of cytoplasmic granules 
through the pore and into target cell (Elmore, 2007). Granzyme A is one of these 
granules, and activates DNA nicking via DNAse NM23-H1(Elmore, 2007). 
Normally, the nucleosome assembly protein SET inhibits the NM23-H1 gene, but 
granzyme A protease cleaves the SET complex thus releasing inhibition of NM23-
H1, resulting in apoptotic DNA degradation (Elmore, 2007). The other granule is 
granzyme B, which cleaves proteins at aspartates and activates procaspase-10 to 
cleave factors like ICAD (Inhibitor of caspase activated DNAse) (Elmore, 2007). 
Gryanzyme B can also directly activate caspase-3 by bypassing the upstream 
signaling pathway (Elmore, 2007). 
Apoptotic mitochondrial events are controlled and maintained by the members of 
Bcl-2 family proteins, and tumor suppressor protein p53 has an important role in 
regulation of the Bcl-2 family members (Cory and Adams, 2002).  
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Figure 1.3 : Schematic demonstration of apoptotic pathways; in addition to two 
main pathways, extrinsic and intrinsic, perforin/granzyme pathway is 
shown (Elmore, 2007). 
1.2.2 Bag-1 and down regulation of apoptosis 
Some cells are resistant to stress, and they need higher levels of apoptotic stimuli for 
cell death (Hersey and Zhang, 2003). A wide variety of inducers including 
physiologycal alterations such as activation of mitogenic signaling pathways (i.e. 
Erk1/2, Akt), inactivation of certain apoptotic molecules (i.e. Fas receptor, Bax) and 
upregulation of anti-apoptotic genes such as Bcl-2 can influence the process of 
apoptosis (Hersey and Zhang, 2003; Duriano, 2008). 
Apoptosis can be blocked in some conditions such as cancer, stress, hipometabolism, 
and aging (Hanahan and Winberg, 2000). Maintenance of homeostasis requires a 
balance between growth and cell death. Any type of parameter that affects the 
balance between growth and cell death can cause uncontrolled cell division and 
subsequently carcinogenesis (Hanahan and Winberg, 2000). 
Bcl-2 protein family members are the most important molecules that regulate 
apoptosis (Youle and Strasser, 2008). Bcl-2 (B-cell lymphoma-2) gene was 
discovered at t(14;18) chromosome translocation breakpoint in B-cell follicular 
lymphomas (Tsujimoto et al. 1985). Bcl-2 family proteins take place in numerous 
biological processes such as prevention and induction of apoptosis (Zha et al., 1996). 
Bcl-2 family members share one or more of the four characteristic domains of 
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homology entitled the Bcl-2 homology (BH) domain (named BH1, BH2, BH3 and 
BH4) motives (Youle and Strasser, 2008) (Figure 1.4).   
Bcl-2 family members have been grouped into three classes (Youle and Strasser, 
2008). One class inhibits apoptosis (Bcl-2, Bcl-XL, Bcl-W, Mcl-1, Bcl-2L10 and 
Bcl-2A1), whereas a second class promotes apoptosis (Bax, Bak and Bok) (Youle 
and Strasser, 2008). The third class of BH3-only proteins (Bad, Bik, Bid, Hrk, Bim, 
Bmf, Noxa and Puma) have a conserved BH3 domain that can bind and regulate the 
anti-apoptotic Bcl-2 proteins to promote apoptosis (Youle and Strasser, 2008). It can 
be seen in Figure 1.4 that Bcl-2 family members have some functional domains such 
as α-helical segments (green bars), transmembrane (TM) domains (red lines). 
Sequence homologies of the BH1 (brown lines), BH2 (grey lines), BH3 (blue lines) 
and BH4 (orange lines) regions are also demonstrated. The three proteins in the 
shaded area are less well studied and cannot be categorized at this time (Youle and 
Strasser, 2008). 
Bag-1 is a novel member of Bag family, which has been discovered via its 
interaction with Bcl-2 (Takayama et al., 1995). In the study of Takayama et al.,1995, 
it has been reported that co-transfection of Bcl-2 and Bag-1 expression plasmids 
rendered Jurkat T cells relatively more resistant to induction of cell death by 
staurosporine, anti-Fas antibody, and cytolytic T cells, whereas either Bcl-2 or Bag-1 
alone was comperatively ineffective at providing protection from cell death 
(Takayama et al., 1995). 
Bcl-2 is not the only interacting partner of Bag-1 during apoptosis. Bag-1 also has 
interactions with other anti- and pro-apoptotic molecules in the cell (Wood et al., 
2009). Bax, Bcl-2, Bcl-XL and p53 have interactions with the Bag-1 isoforms, and 
these are crucially significant for tumorigenesis (Wood et al., 2009). Activation of 
the pro-apoptotic molecule Bax with an apoptotic inducer, involves subcellular 
translocation and dimerization (Gross et al., 1999). A substantial portion of Bax is 
monomeric and found in the cytosol or loosely attached to membranes in viable cells 
(Gross et al., 1999). However, following a death stimulus, cytosolic and monomeric 
Bax translocates to the mitochondria where it becomes an integral membrane protein 
and cross-linkable as a homodimer (Gross et al., 1999). In addition to Bax, Bak can 
also present conformational changes after induction of a death stimulus (Gross et al., 
1999), but the presence of an anti-apoptotic molecule such as Bcl-2 or Bcl-XL can 
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Figure 1.4 : Sequence alignment of Bcl-2 family proteins and BH3-only proteins 
(Youle and Strasser, 2008). 
inhibit the activation of Bax folloving a death signal (Gross et al., 1998). Bcl-2 is an 
integral membrane protein heavily localized to mitochondria (Gross et al., 1998). It 
can be thought that Bcl-2 alone is not sufficent to inactivate Bax for the suppression 
of apoptosis. Therefore, Bag-1 is the found partner of Bcl-2 in the enhancement of its 
anti-apoptotic function (Takayama et al., 1995). It is explained that the reason for 
this might be the increased anti-apoptotic protein amounts on the mitochondria with 
the involvement of Bag-1. In a study, Bag-1 silenced HeLa-AS cells showed 
increased sensitivity to apoptosis incuced by chemotherapeutic drugs including 
staurosporine, paclitaxel, ATRA, and 4-HRP (Xiong et al., 2003). Underexpression 
of Bag-1 leads to decreased Bcl-2 levels and increased release amounts of 
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cytochrome c, leading to a increased sensitivity to apoptosis (Xiong et al., 2003). In 
Bag-1 silenced cells, Bax aggregation has been observed, which explains the 
Bax/Bcl-2 ratio change in mithochondria (an important parameter for apoptosis) 
(Xiong et al., 2003). 
More importantly, a pro-apoptotic member of Bcl-2 family, Bad, inhibits Bcl-XL 
activity and thereby promotes Bak and Bax aggregation (Datta et al., 1999). This 
situation subsequently leads to ‘cytochrome c’ release to the cytosol, caspase 
activation and finally to apoptosis (Datta et al., 1999). Bad phosphorylation is 
important for the determination of cell fate. Phosphorylation of Bad from serines at 
the 112, 136 and 155 sites, rescue cells from apoptosis and modulates cell survival 
through interactions with 14-3-3 proteins (Peruzzi et al.,1999; Peso et al., 1997). 
It has been ascertained that 14-3-3 has been found in the epigenetic mechanisms of 
cancer cells (Jelinek et al., 1994). As it is a histone kinase, it can bind to chromatin-
modifying enzymes and transcriptional regulators such as histone deacetylases 
(HDACs), histone acetyltranferases (HATs), TATA-binding protein (TBP), and p53 
(Jelinek et al., 1994). When it gets recruited with p53, they can regulate Bag-1 
expression together. Once Raf-1 interacts with MEK, one of the MAP kinase 
modulators, it is targeted to nucleus to perform its epigenetic function (Jelinek et al., 
1994). For this purpose, 14-3-3 may facilitate Raf-1 interaction with MEK in cytosol 
(Jelinek et al., 1994). 
Phosphorylation of Akt is another important parameter for cell survival (Götz et al., 
2005). Inhibition of apoptosis by Bad phosphorylation from serine 136 residue is 
maintained by activated Akt protein (Götz et al., 2005). In absence of Bag-1, Raf-1 
activation and Akt phosphorylation are not sufficient to prevent apoptosis (Götz et 
al., 2005). 
In a study with neuronal cells, Bag-1-related cell survival mechanism was 
investigated (Frabel et al., 2007). They create the model shown in Figure 1.5 to 
explain interactions during cell survival (Frabel et al., 2007). They claimed that Bag-
1 forms a comlex with phosphotylated Akt, Hsp70, B-Raf and Bcl-2, and this 
complex phosphorylates Bad at Ser136. (Frabel et al., 2007). Phosphorylated Bad 
interacts with 14-3-3 scaffold protein instead of providing oligodimerization of pro 
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apoptotic proteins on mithochondrial membrane, and it leads cells to survival (Frabel 
et al., 2007).  
 
Figure 1.5 : A possible model of Raf-1 and Akt activation and regulation 
mechanism by Bag-1 (Frabel et al., 2007). 
1.3. Bag-1’s relationship with cancer and cell survival 
Breast cancer is the most commonly occuring cancer in women, comprising 23% of 
all female cancers in the world, with an estimated 1.15 million cases diagnosed in 
2002 (Ozmen, 2008). The lifetime risk of a woman developing invasive breast cancer 
is 12.6%, one out of 8 women in the United States will develop breast cancer at some 
point in her life (Richie et al., 2003). Distribution of breast cancer incidence in 2000s 
alters in different regions of Turkey due to the geographic, economic, social and 
cultural factors (Ozmen, 2008). Breast cancer incidence in western part of Turkey 
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(50/100.000) is more than two times in eastern part of Turkey (20/100.000) because 
of “Westernizing life” (early menarche, late menopause, first birth over 30 years, less 
breast feeding, etc.), and other related factors (Ozmen, 2008). It is known that Bag-1 
is highly expressed in breast cancer cells (Sharp et al., 2004). Delineating the role of 
Bag-1 in breast cancer may provide new targeting strategies for both treatment and 
diagnosis of breast cancer. For this reason we chose MCF-7 human breast 
adenocarcinoma cell line which had been obtained from mammary gland of 
mammarial ephitelium. MCF-7 cells are estrogen receptor dependent cells isolated 
from a 69-year-old Caucasian female patient in 1970, and was established in 1973 
(ATTC datasheet). 
Bag-1 has many critical roles in the cell through its interactions with certain target 
molecules to regulate cancer, differentiation, motility and transcription (Cutress et 
al., 2002). Cell survival and apoptosis are the two major pathways that Bag-1 
involves (Cutress et al., 2002). It is known that Bag-1 is overexpressed in cancer 
cells in comparison with the normal cells, thus Bag-1 can be used a prognostic 
marker for cancer (Cutress et al., 2002). As it is shown in Figure 1.6, Bag-1 interacts 
with a wide range of proteins to regulate different molecular mechanism in the cell 
(Wang et al., 1998). Bag-1 interactions with target proteins, and how they affect 
those mechanisms will be explained in following paragraphs. 
 
Figure 1.6 : Bag-1 interacting partners and their functions in the molecular 
pathways (adapted from Wang et al., 1998). 
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It has been previously reported that upregulation of Bag-1 protein expression is done 
by tumour-derived mutant p53. p53 is one of the molecules in cancer development, 
and the overexpression of Bag-1 in human cancer cells may arise from the 
transactivation of Bag-1 promoter by p53 mutants (Yang et al., 2008). Hence, Bag-1 
overexpression in cancer cells may inhibit the apoptotic pathways using mutant p53 
feedback loop (Yang et al., 2008). Also it has been demonstrated that Bag-1 inhibits 
p53-induced apoptosis, which has an impact on resistance for radiotherapy or 
chemotherapy (Oorschot et al., 1997). 
Another important molecule in the cell is NF-κB which has been recently found to be 
regulated by Bag-1(Clemo et al., 2008). It is indicated that NF-κB inhibition is 
caused by Bag-1 gene knockdown and due to this relationship, Bag-1 can be used as 
an adjuvant for increasing the sensitivity of current therapeutic regimes (Clemo et al., 
2008). siRNA-mediumted Bag-1gene silencing has also induced apoptosis in 
colorectal carcinoma cells via TRAIL and TNF-α that are found in extrinsic 
apoptotic pathway (Clemo et al., 2008). It has been showed that Bag-1 is significant 
for the regulation of NF-κB and IκBα, both involve activation of glucocorticoid 
receptors (Chen et al., 1995). In resting cells, most of NF-κB is bound to IκBα, and 
forms a very stable complex to protect IκBα degradation and inhibits NF-κB; both, 
nuclear localisation and transcriptional activation (Chen et al., 1995). Along with the 
stimulation, IκBα is phosphorylated by the IκB kinase (IKK) complex, and it targets 
IκBα for polyubiquitination and degradation in the 26S proteosome and causing the 
release of the NF-κB heterodimers (Chen et al., 1995). Further studies revealed that 
in the absence of Bag-1 phosphorylation and degradation of IκBα in response to 
pharbol complexes is elevated, and nuclear accumulation of NF-κB p65-p50 is 
significantly decreased (Maier et al., 2010). Furthermore, a recent study describes a 
novel role of Bag-1, sugesting Bag-1 as a co-regulator of gene expression via 
interaction with the p50-p50 NF-κB complexes (Southern et al., 2011). This study 
demonstrated that Bag-1 expression is elevated in the developing colorectal adenoma 
throught to metastatic lesions, which can be a sign for Bag-1’s function as a selective 
regulator of p50-p50 NF-κB responsive genes in colorectal tumour cells (Southern et 
al., 2011). 
It has been reported that Rb, mutifunctional protein with important roles in cell cycle 
regulation and apoptosis, interacts with Bag-1 (Arhel et al., 2003). Blocking of 
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Rb/Bag-1 interaction causes a change in the subcellular localisation of Bag-1 (Arhel 
et al., 2003). Since Rb/Bag-1 interaction has been detected in both adenoma- and 
carcinoma- derived cell lines, Rb-maintained nuclear localisation of Bag-1 is 
important for colorectal tumour progression (Arhel et al., 2003). Also it has been 
identified that following γ-radiation there is an alteration in subcellular localisation 
of Bag-1 (Barnes et al., 2005). They suggested that localisation change of Bag-1M 
(translocation) makes cells more sensitive to apoptosis (Barnes et al., 2005).  
In a study about mouse liver progenitor cells, it has been shown that the effect of 
HGF (hepatocyte growth factor) on cell survival was increased by the overexpression 
of exogenous Bag-1 (Bardelli et al., 1996). Although it is known that C-terminal 
domain of Bag-1 binds to HGF receptor efficiently, overexpression of this region 
alone has no effect on the anti-apoptotic activity of HGF (Bardelli et al., 1996). 
These results indicate a possible interplay between Bag-1 and different growth factor 
receptors in the prevention of apoptosis and stimulation of cell survival (Bardelli et 
al., 1996). 
Nuclear hormone receptors (NHRs) are another key targets for Bag-1 isoforms 
(Sharp et al., 2004). NHRs are ligand dependent transcription factors of which target 
genes take part in a wide range of cellular processes such as controlling cell growth, 
motility, cell division, apoptosis, differentiation and morphology (Cato and Mink, 
2001). Bag-1 interacts with several NHRs inluding glucocorticoid receptors (GRs), 
estrogen receptors (ERs), androgen receptors (ARs), retinoic acid receptor (RAR), 
thyroid receptor, vitamin D3 receptor (VDR), progesterone receptor (PR) and 
mineralocorticoid receptor (MR). Bag-1 isoforms affect these receptors diversely. 
Interactions of Bag-1 isoforms with indicated receptors can be seen in Table 1.1. 
Table 1.1 : Effects of Bag-1 isoforms on nuclear hormone receptors (adapted from 
Sharp et al., 2004). 
Receptor 
Effect of Bag-1 
overexpression 
Active Bag-1 
isoforms 
References 
Vitamin D receptor Activates/Inhibits 
Bag-1L (not Bag-
1S/M) 
Guzey et al., 2000 
Witcher et al., 2001 
Androgen receptor Activates 
Bag-1L (not Bag-
1S/M) 
Froesch et al., 1998 
Knee et al.,2001 
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Table 1.1 7 (continued) : Effects of Bag-1 isoforms on nuclear hormone receptors       
(adapted from Sharp et al., 2004).  
Glucocorticoid 
receptor 
Inhibits Bag-1M/L 
Schneikert et al., 
2001 
Retinoic acid receptor Inhibits Bag-1S Liu et al., 1998 
Thyroid hormone 
receptor 
Inhibits Bag-1S Liu et al., 1998 
Estrogen receptor Activates 
Bag-1L (not Bag-
1S/M) 
Cutress et al., 2003 
Progesterone receptor Inhibits Bag-1M Knapp et al., 2012 
Mineralocorticoid 
receptor 
Inhibits Bag-1M Knap et al., 2012 
It has been reported that Hsp70 has a role as a direct negative regulator of Bag-1, and 
consequently as an indirect regulator of downstream effectors such as important 
serine/threonine kinase Raf-1 (C-Raf) (Song et al., 2001). They also have shown that 
function of Bag1 is to coordinate the cellular signals that determine the growth state 
of the cell with its environmental and physiological state; and they predicted that 
there may be a number of other points of regulatory crosstalk to ensure the various 
components of the cell growth biosynthetic apparatus are in communication with 
heat-shock proteins or other, unidentified, stress signaling molecules (Song et al., 
2001). Bag-1 interacts with Raf-1 kinase from its C-terminus. Ras activates Raf-1 in 
order to tranduce a stimulation to mitogen-activated protein (MAP) kinase cascade. 
Also, it has been reported that Bag-1 uses a Ras-independent pathway for the Raf-1-
dependent activation of the downstream MAP kinases (Song et al., 2001). They 
showed that Bag-1 mutants (deficient in binding to Hsp70) constitutively stimulated 
Raf-1/ERK activities, such that DNA synthesis was not repressed by heat shock 
(Song et al., 2001). They also showed that Hsp70 mutants (defective in binding to 
Bag-1) had no effect on Raf-1 activity and DNA synthesis when overexpressed 
(Song et al., 2001). These results suggest that down regulatory effects of Hsp70 on 
MAP kinase pathway and DNA synthesis require Bag-1interaction (Song et al., 
2001). Also, Bag-1 interacts with E3 ligases CHIP and Siah-1 to stimulate CHIP-
mediumted ubiquitylation of Raf-1 (Demand et al., 2001; Arndt et al., 2005). 
Apart from its relationship with cancer, Bag-1 is an important molecule that gets 
involved in the regulation of cell survival and proliferation (Wang et al., 1996). In a 
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recent study it is indicated that the overexpression of Bag-1 in immortalized cell line 
Mcf-10A (also defined as normal breast epithelial cells) led to an attenuation of 
luminal apoptosis which is charecterized by an increased number of acini with filled 
lumens and enhanced caspase-3 activation (Anderson et al., 2010). In Bag-1-
expressing acini, there is an enhanced activation of Raf-1 (C-Raf) protein which is 
known to influence both mitogenic and anti-apoptotic pathways (Anderson et al., 
2010). Furthermore subsequent activation of a downstream signaling cascade 
through the phosphorylation of MEK and ERK1/2 might be the evidence of direct 
interaction of Bag-1 and Raf-1, though it is opposite to Bag-1’s role in protecting 
against heat shock-induced apoptosis, in which its survival effects are dependent on 
Hsp70/Hsc70 binding and not on interaction with Raf-1 (Anderson et al., 2010) 
(Figure 1.7). 
In another study on Bag-1 silenced mice with acute myeloid leukemia (AML) 
revealed that although Bag-1 does not have a direct anti-apoptotic role in AML, it is 
found to be important to control apoptosis in AML via its interactions (Aveic et al., 
2011). Silencing Bag-1 affected the MAPK-pathway, specificially through down-
regulation of ERK1/2 activity, and proliferative pathways (Aveic et al., 2011). 
However, it has been reported that in HeCaT epidermal keratinocytes, Bag-1 inhibits 
both proliferation and cell motility (Hinitt et al., 2011).  
 
Figure 1.7 : A model of interaction between Raf-1 and Bag-1, and Raf-1 activation 
through phosporylation from serine 388 by Bag-1, resulting cell 
survival (Anderson et al., 2010). 
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1.4. Aim of the study 
Bcl-2 associated athanogene family (athano = against death in Greek) proteins are 
discovered by co-immunoprecipitation with Bcl-2 anti-apoptotic protein. Bag genes 
are evolutionally conserved and their homologs exist in yeasts, plants and animals. 
Bag family members control the cell homeostasis in two different ways: (1) They 
contribute to maintain cell’s vital activity under normal and stress conditions via 
regulating both positively and negatively the cycle of Hsp70/Hsc70 molecular 
chaperone system. For instance, the direction of the cell balance under normal and 
stress conditions are maintained by competitive binding of Hsp70 or Raf-1 to Bag-1. 
(2) They form complexes with transcription factors and nuclear hormone receptors 
which are controlling various physiological processes such as apoptosis, 
tumorigenesis, neural differentiation and cell cycle independent from Hsp70/Hsc70 
system. 
Even though Bag-1 involves a number of molecular pathways in the cell, none of 
them had been completely understood. Every cell type shows variations in the 
response of Bag-1 manipulations. In this study, we would like to understand the 
molecular mechanism of Bag-1-related cell survival in particularly estrogen receptor 
dependent breast cancer cell lines. 
It is known that Bag-1 inhibits apoptosis and promotes cell survival, but molecular 
players or crosstalk between Bag-1 involved pathways are not clear yet. Once 
interacting partners of Bag-1 are elucitated in MCF-7 cells, Bag-1-related cell 
survival pathway will be understood. This will, in the long term, allow routes for the 
design of small molecules to manipulate the interactions of Bag-1, and, therefore 
offer solutions for estrogen receptor dependent cell cancer therapy. 
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2.  MATERIALS and METHODS 
2.1  Materials 
2.1.1. Equipment 
Equipment used in this study is shown in the table 2.1. 
Table 2.1 : Laboratory equipment used in the study. 
Equipment Supplier Company 
Laminar Air Flow Cabinets FASTER BH-EN 2003 
Pipettes 
2.5 μL, 10 μL, 100 μL, 200 μL, 1000 
μL, Gilson 
Electronic Pipette Finnpipette Thermo 
Centrifuges 
Biolab SIGMA 6K15, Beckman 
Coultier Microfuge®18, Beckman 
Coulter AvantiTM J-30 I, IECCL10 
Centrifuge, 
Thermo Electron Corporation, Labnet, 
Labnet International C1301-230V 
Quick Spin Labnet International, C1301-230V 
Magnetic stirrer Dragon Lab, MS-H-S 
pH Meter Mettler Toledo, Five Easy 
Light Microscope Olympus CH30 (USA) 
Hemacytometer FisherLab Scientific, 0267110 
High Pressure Steam Sterilizer TOMY SX-700E 
Precision Balance Precisa 620C SCS 
Balance Precisa BJ 610 C 
Ice Machine Scotsman AF 10 
SDS-PAGE Gel Electrophoresis 
System 
BIO-RAD MiniProtean 
Microwave Arcelik MD582 
Spectrophotometers 
Shimadzu, UV-1601 
Thermo Scientific NanodropTM 2000c 
BIO-RAD Benchmark Plus 
Water Baths Memmert, Elektro-mag M 96 KP 
Vortex Dragon Lab MX-F 
Incubator with CO2 Biolab SHEL LAB 
Shaker 
Forma Orbital Shaker, 
Thermo Electron Corporation 
Freezers 
Bosch (+4
o
C), 
Bosch (-20
o
C), 
New Brunswick Scientific (-80
o
C) 
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Table 2.1 (continued) : Laboratory equipment used in the study.  
TCS SP2 SE Confocal Microscope Leica, Microsystems 
Kodak Medical X-ray Processor Kodak 
Trans-Blot® Turbo™ Transfer 
System 
BIO-RAD 
DynaMag-2 Magnet Invitrogen 
Trans-Blot® SD Semi-Dry Transfer 
Cell 
BIO-RAD 
Power Supply 
EC250-90 Apparatus Corporation 
BIO-RAD 
Inverted Fluorescent Microscope Olympus DC71 
 
2.1.2 Commercial kits 
Commercial kits used in this study are shown in the table below. 
Table 2.2 : Commercial kits used in the study. 
Kit Supplier Company 
QIAprep Spin Miniprep Plasmid 
Purification Kit 
Qiagen, 27106 
QIAGEN Plasmid Midi Kit Qiagen, 12145 
QIAGEN EndoFree Plasmid Maxi Kit Qiagen, 12362 
20X LumiGLO® Reagent and 20X 
Peroxide 
Cell Signaling, 7003 
SuperSignal® West Femto Maximum 
Sensitivity Substrate 
Thermo, 34094 
Restore Western Blot Stripping 
Buffer 
Thermo, 21059 
Lipofectamine™ 2000 Transfection 
Reagent 
Invitrogen, 11668-019 
Bag-1 siRNA (h) Santa Cruz, sc-29211 
Trans-Blot® Turbo™ Midi 
Nitrocellulose Transfer Packs 
BIO-RAD, 170-4159 
ProteoJET™ Mammalian Cell Lysis 
Reagent 
Fermantas, K0301 
XTT Cell Viability Kit Cell Signaling, 9095 
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Table 2.2 (continued) : Commercial kits used in the study. 
cOmplete Lysis-M Kit EDTA-free Roche, 04719964001 
TransPass™ D2 Transfection Reagent BioLabs, M2554S 
PhosSTOP Roche, 04906845001 
Quick Start Bradford Protein Assay 
Kit 
BIO-RAD, 500-0203 
X-tremeGENE HP DNA Transfection 
Reagent 
Roche, 06366236001 
Erase-It® Background Eliminator Thermo, 21065 
Dynabeads® Magnetic Beads Invitrogen, 100-03D 
 
2.1.3. Bacterial Assay 
 Tryptone (BDH Laboratory) 
 Yeast Extract (Merck) 
 NaCl (Fluka) 
 Agar (Merck) 
 Ampicillin (Sigma-Aldrich) 
 Neomycin (Sigma-Aldrich) 
 Glycerol (Fluka) 
2.1.4. Cell culture assay 
 25 cm2, 75 cm2 Tissue Culture Flask (TPP) 
 6 well, 24, 96 well Culture Plate (TPP) 
 5 mL, 10 mL, 25 mL Serological Pipettes (TPP) 
 250, 500 mL Vacuum Filtration System (TPP) 
 Poly-L-Lysine (Sigma-Aldrich) 
 0,22 μm Syringe Filtre (TPP) 
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 10 mL, 20 mL Syringe (Set Inject) 
 DAPI ( Invitrogen) 
 Acridine orange (Applichem) 
 PI (Applichem) 
 Dioc6 (Fluka) 
 Trypan blue (Sigma-Aldrich) 
 Dulbecco’s Modified Eagle Medium (DMEM) 1X (Gibco) 
 Opti-MEM Reduced Serum Medium 1X (Gibco) 
 Fetal Bovine Serum (FBS) (Gibco) 
 RNAse-free water (Santa Cruz) 
 Penicilin/Streptomycin Solution 100X (Biochrom) 
 Trypsin-EDTA 0,25/0,02 Solution (Biochrom) 
 Phosphate Buffered Saline (PBS) 10X pH=7,2 (Gibco) 
 Dimethylsulphoxide (DMSO) (Fiedel-de Haën) 
 Cell Scrapper (TPP) 
2.1.5 Protein assay 
 SDS (AppliChem) 
 TEMED (AppliChem) 
 Dithiothreitol (DTT) (Merck) 
 β-Mercaptoethanol (Merck) 
 Acrylamide (Sigma Aldrich) 
 Bis-acrylamide (Sigma Aldrich) 
 PMSF (AppliChem) 
 Bromophenol Blue (Merck) 
 Ammonium persulphate (APS) (Sigma-Aldrich) 
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 Biotinylated Protein Ladder (Cell Signaling) 
 Prestained Protein Ladder  (Fermantas) 
 Nitrocellulose Paper (BIO-RAD) 
 3MM Whatman Filter Paper (Whatman) 
 Tween-20 (AppliChem) 
 Skimmed milk powder (%5) (OXOID) 
 Bovine Serum Albumin (BSA) (Sigma-Aldrich) 
 Alexa Flour 488 goat anti-rabbit (Invitrogen) 
 Alexa Flour 647 goat anti-mouse (Invitrogen) 
 DAPI (Sigma) 
 Mounting Medium (Sigma) 
2.1.6 Antibodies 
All antibodies (both primary and secondary) were purchased from Cell Signaling 
Technologies of which properities are shown in the table below. 
Table 2.3 : Primary antibodies used in this study. 
Antibody Type, Source Dilution 
α-Bag-1 Monoclonal, Mouse 1:500 
α-β-actin Monoclonal, Rabbit 1:500 
α-Bcl-2 Monoclonal, Rabbit 1:250 
α-Bax Polyclonal, Rabbit 1:250 
α-Bad Polyclonal, Rabbit 1:250 
α-Bim Polyclonal, Rabbit 1:250 
α-Phospho-Bad (Ser136) Polyclonal, Rabbit 1:250 
α-C-Raf Polyclonal, Rabbit 1:500 
α-Phospho-C-Raf 
(Ser338) 
Monoclonal, Rabbit 1:500 
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Table 2.3 (continued) : Primary antibodies used in this study.  
α-Phospho-C-Raf   
(Ser289/296/301) 
Polyclonal, Rabbit 1:500 
α-B-Raf Monoclonal, Rabbit 1:500 
α-Phospho-B-Raf 
(Ser445) 
Polyclonal, Rabbit 1:500 
α-A-Raf Polyclonal, Rabbit 1:500 
α-p44/42 MAPK 
(Erk1/2) 
Monoclonal, Rabbit 1:1000 
α-MEK1/2 Polyclonal, Rabbit 1:1000 
α-Phospho-MEK1/2 
(Ser217/221) 
Polyclonal, Rabbit 1:1000 
α-Phospho-Akt (Ser473) Monoclonal, Rabbit 1:500 
α-Hsp70 Polyclonal, Rabbit 1:500 
Table 2.4 : Secondary antibodies used in this study. 
Antibody Epitope Type Dilution 
Goat-α-Mouse Mouse-IgG 
Polyclonal 
goat; 
HRPconjugated 
1:5000 
Goat-α-Rabbit Rabbit-IgG 
Polyclonal 
goat; 
HRPconjugated 
1:5000 
2.1.7 General Chemicals 
General chemicals which were used in this study are listed in the table below. 
Table 2.5 : General chemicals used in this study. 
Substance Supplier Company 
Ethanol Riedel- de Haёn 
Methanol Riedel- de Haёn 
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Table 2.5 (continued) : General chemicals used in this study. 
Isopropanol Fluka 
HCl AppliChem 
NaOH AppliChem 
Glicial acedic acid Fluka 
Glycerol Fluka 
Glycerol Merck 
Tricine Merck 
Glucose Merck 
2.1.8 Buffers and solutions 
2.1.8.1 Separating acrylamide solution 
Separating acrylamide solution was used for preparation separating gel. The amount 
and content of solution is given in Table 2.6. 
Table 2.6 : Content of separating acrylamide. 
Content Amount 
Acrylamide 46,5 g 
Bis-acrylamide 1,5 g 
dH2O up to 100 mL 
2.1.8.2 Stacking acrylamide solution 
Stacking acrylamide solution was used for the preparation of stacking gel. The 
amount and content of solution is given in Table 2.7. 
Table 2.7 : Content of stacking acrylamide. 
Content Amount 
Acrylamide 48 g 
Bis-acrylamide 1,5 g 
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Table 2.7 (continued) : Content of stacking acrylamide. 
dH2O up to 100 mL 
2.1.8.3 6X sample buffer  
6X sample buffer was used to denature protein samples which were loaded on SDS-
polyacrylamide gel. Content of 6X sample buffer is shown in Table 2.8. 
Table 2.8 : Content of 6X sample buffer. 
Content Amount 
SDS 1,2 g 
Bromophenol blue 6 mg 
Glycerol 4,7 mL 
0,5M Tris-HCl (pH: 6,8) 1,2 mL 
dH2O 2,1 mL 
It was warmed and shaked until it dissolved, and 930 mg DTT or 5% β-
Mercaptoethanol was added. 
2.1.8.4 Running buffer for SDS-PAGE 
Anode and the cathode buffers, both were used as SDS-PAGE running buffer, and 
their contents are given in Table 2.9 and Table 2.10, respectively. 
Table 2.9 : Content of 1X anode buffer. 
Content Concentration Amount 
Tris-Base 0,2M 24,22 g 
dH2O  Up to 1 L (pH=8,9) 
Table 2.10 : Content of 1X cathode buffer. 
Content Concentration Amount 
Tris-Base 0,1 M 182 g 
Tricine 0,1 M 17,92 g 
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Table 2.10 (continued) : Content of 1X cathode buffer. 
SDS  1 gr (1%) 
dH2O  Up to 1 L (pH=8,25) 
2.1.8.5 10X TBS buffer 
TBS (with HCl) was prepared and used as blocking and washing buffer during 
Western blot analysis. 10X stock solution was diluted to 1X concentration with 
dH2O to obtain working solution. Content of TBS buffer is shown in Table 2.11. 
Table 2.11 : Content of 10X TBS buffer. 
Content Concentration Amount 
Tris-base 25 mM 3 g 
Glycine 192 mM 14,4 g 
Methanol 20 % 200 mL 
SDS 0,05 % 0,05 g 
dH2O  up to 1 L 
2.1.8.6 TBS-T buffer 
TBS-T solution was prepared for washing in Western blot analysis. Preparation of 
this buffer is shown in Table 2.12. 
Table 2.12 : Content of TBS-T buffer. 
Content Concentration Amount 
TBS 1X 1 L 
Tween-20 0,05 % 500 μL 
2.1.8.7 Blocking and incubation buffer  
Blocking and incubation buffer was used for blocking of membrane and incubation 
with primary antibody. Preparation of this buffer is shown in Table 2.13. 
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Table 2.13 : Content of blocking and incubation buffer. 
Content Concentration Amount 
TBS-T 1X 100 mL 
Skimmed milk or BSA  5 g 
2.1.8.8 PBS solution 
PBS solution was prepared by dissolving 1 PBS tablet within 100 mL dH2O. 
2.1.8.9 PBS-T solution 
To prepare PBS-T solution, 2 mL Tween-20 was added into 1 L PBS solution. 
2.1.8.10 Elution buffer for immunoprecipitation 
50 mM Glycine (pH 2,8) was prepared and used as elution buffer 
2.1.9 Bacterial strain 
Escherichia coli DH5α strain [F-, φ80dlacZΔM15, Δ(lacZYA-argF)U169, deoR, 
recA1, endA1, hsdR17(rk-, mk+), phoA, supE44, λ-, thi-1, gyrA96, relA1] 
2.1.10 Bacterial culture medium and solution 
2.1.10.1 LB medium 
Luria Bertani (LB) Medium was prepared by dissolving 10 g tryptone, 5 g yeast 
extract, and 10 g NaCl in 1L dH2O. The medium was sterilized by autoclaving for 15 
minutes (min) at 121°C. To prepare a selective medium, 50 μg/L ampicillin or 
neomycin was added after the medium was cooled down approximately to 55°C. 
2.1.10.2 LB-agar medium 
LB-Agar Medium was prepared by dissolving 10 g tryptone, 5 g yeast extract, 10 g 
NaCl and 20 g agar in 1L dH2O. The medium was sterilized by autoclaving for 15 
min at 121°C. To prepare a selective medium, 50 μg/L ampicillin was added after the 
medium was cooled down approximately to 55°C. After mixing the medium with 
ampicillin, the content was poured into 10 mm petri plates. 
2.1.10.3 SOC medium 
SOC medium was used to cultivate E. coli for 1 hour (h) after heat shock during 
transformation. 2 g tryptone, 5 g yeast extract, 0,058 g NaCl, 0,0186 g KCl, 0,095 g 
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MgCl2, 0,23 g MgSO4 and 0,36 g glucose was resolved in 100 mL dH2O and 
sterilized at 121
o
C by autoclaving for 15 min. 
2.1.10.4 CaCl2 solution 
CaCl2 solution was used in the preparation chemically competent E. coli cells that 
were further used in transformation. The solution contains 60 mM CaCl2, 10mM 
PIPES and 15% glycerol in dH2O. pH was adjusted to 6,4 to dissolve PIPES and then 
was filter sterilized with 0,2 μm filter. 
2.1.11 Plasmid 
CS-L0198-M02 of OmicsLink Expression Clone was used as plasmid. Bag-1 human 
cDNA ORF Clone was inserted in pEZ-M02 vector after the removal of the stop 
codon and addition of a C-terminal TAP (tandem affinity purification)-tag containing 
sequentially CBP (calmodulin binding peptide) – TEV (tobacco etch virus protease)- 
Protein A from N to C terminus by Capital Biosciences. Whole plasmid size is 7285 
bp with the 1038 bp ORF length. Ampicillin is the antibiotic for this plasmid, and 
neomycin is the stable selection marker. DH5α is the suitable bacterial strain for 
transformation. 
2.1.12 Vector 
pEZ-M02 vector information for Bag-1 overexpressing plasmid is demonstrated in 
Figure 2.1. 
 
Figure 2.1 : Vector information for Bag-1 overexpressing plasmid. 
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2.1.13 Cell Line 
MCF-7 cells are human breast adenocarcinoma cells which was derived from a 
metastatic site. Cell line was obtained from mammary gland of mammarial 
ephitelium. MCF-7 cells are adherent, estrogen receptor positive and expressed in 
blood type O Rh+. This cell line which has a doubling time of about 29 hours, was 
isolated from a 69-year-old Caucasian female patient in 1970, and was established in 
1973. 
2.1.14 Cell culture solutions 
2.1.14.1 MCF-7 culture medium 
MCF-7 cell culture medium is Gibco including containing 4500 mg/L D-Glucose, 
110 mg/L Sodium Pyruvat. It was prepared with 10% FBS and 1% 
Penicillin/Streptomycin within DMEM (Dulbecco’s Modified Eagle Medium) and 
then filter sterilized with a 0,2 μm filter. 
2.1.14.2 MCF-7 freezing medium 
For the preparation of MCF-7 freezing medium, 5% DMSO was supplemented to the 
serum free culture medium and sterilized with 0,2 μm filter 
2.1.15  Bag-1 siRNA 
Human Bag-1 siRNA was obtained from Santa Cruz and is a target-specific 19-25 nt 
siRNA designed to knock down gene expression. Each vial contains 3.3 nmol of 
lyophilized siRNA, sufficient for a 10 μM solution. Bag-1 siRNA was resuspended 
with 330 μL RNAse-free water and stored at -20oC. 
2.2. Methods 
2.2.1 Competent cell preparation - CaCl2 method  
The bacterial competent cells have been chemically treated to allow the foreign DNA 
or plasmid to be taken in. E. coli-DH5α cells were taken from a glycerol stock 
culture by scraping with a tip, and it was put in 5 mL LB medium and incubated 
overnight at 37
o
C in orbital shaker. The following day, 100 mL LB medium was 
inoculated with 5 mL culture solution and was incubated at 37
o
C in orbital shaker. 
Cell density was measured by a spectrophotometer at optical density (OD) 600, and 
when it was reached to 0.6 the bacteria were transferred to 50 mL prechilled sterile 
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ultracentrifuge tubes and incubated on ice for 10 min. The cells were centrifuged at 
1600xg for 7 min at 4
o
C, and then supernatant was discarded. Each bacterial pellet 
was resuspended in 10 mL ice-cold CaCl2 and centrifuged for 5 min at 1600xg, and 
the supernatant was discarded. After centifugation, each bacterial pellet was 
resuspended in 10 mL ice-cold CaCl2, and they were incubated on ice for 30 min. 
Then, centrifgation was performed again at 1600 x g for 5 min at 4
o
C, and each pellet 
was resuspended completely in 2 mL of CaCl2. The competent cells were distributed 
into prechilled sterile microfuge tubes each containing 50 μL and they were stored at 
-80
o
C. For 50 mL CaCl2 solution content is shown in Table 2.14. 
Table 2.14 : CaCl2 solution content. 
Content Concentration Amount 
CaCl2.2H2O 60 mM 0,442 g 
PIPES 10 mM 0,15 g 
Glycerol 15 % 7,5 mL (from 100 %) 
dH2O  Up to 50 mL 
2.2.2 Transformation  
For the transformation, competent cells were taken out from -80
o
C and thawed on 
ice. Purified plasmid DNA was mixed with competent cells and the tube was 
incubated on ice for 30 min. Then the tube was placed in 42
o
C for 45 sec and put 
back on ice for 2 min. 80 μL SOC medium was added and then culture was incubated 
at 37
o
C for 1 h in orbital shaker. Culture was plated on selective medium with 
appropriate antibiotic (LB-Amp). Plates were incubated overnight at 37
o
C. 
2.2.3 Small scale plasmid DNA preparation (mini-prep) 
Plasmid preparation was performed using QIAGEN, QIAPrep Spin Miniprep Kit for 
small scale (mini) preparation, following the instructions of the manufacturer. In this 
procedure, plasmid DNA was released from bacteria by alkaline lysis, and lysate was 
removed from the RNA by RNase. Then in the presence of chaotropic salt (guanidine 
HCl), DNA has an ability to bind selectively to glass fiber fleece in a centrifuge tube 
and remained bound. Washing steps was performed to remove contaminating 
bacterial components, and then low salt elution buffer was added to remove DNA 
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from the glass fiber fleece. After identification of the colonies containing the Bag-1L 
over-expressing plasmid, these colonies were taken into a 5 ml LB medium 
containing 5 μl suitable antibiotic (ampicilin) to prepare selection medium. Then, 
they were incubated overnight with vigorous shaking (200 rpm) at 37
o
C. Plasmid 
preparation was performed using QIAGEN, QIAPrep Spin Miniprep Kit for small-
scale (mini) preparations, following instructions of the manufacturer.  
2.2.4 Medium scale plasmid DNA preparation (midi-prep) 
Bag-1 constructs were transformed with E. coli DH5α strain. After the colonies rt 
containing our insert were reproduced in medium scale and purified with QIAprep 
Spin. 
2.2.5 Determination of plasmid DNA concentration  
The spectrophotometric analysis was used to determine recovery, purity and 
concentration of nucleic acid. The ratio of absorption at 260 nm vs 280 nm is 
commonly used to evaluate the purity of DNA with respect to protein contamination, 
since protein (in particular, the aromatic amino acids) absorbs at 280 nm. According 
to the literature, the ratio of absorbance (A260/A280) of a pure DNA solution is 
between 1,8 to 2,0. When protein contamination increases, the ratio decreases. 2 μL 
sample was placed onto a sensor and its concentration was determined with the help 
of NanoDrop 2000/2000c Operating Software. 
2.2.6 Preparation of cell culture  
2.2.6.1 Transferring the stock cell to culture flask  
A frozen stock of MCF-7 cells were taken from -80
o
C and after the cells were 
thawed in 37
o
C water bath. They were diluted with MCF-7 culture medium, and 
centrifuged for 3 min at 1000 rpm. Cell pellet was dissolved with medium and 
transferred to the culture flasks. 
2.2.6.2 Cell counting 
Growing medium was removed and cells were detached by 1 mL Trypsin-EDTA 
treatment for 2 min at 37
o
C. Then trypsin-EDTA solution was inhibited by 10 mL 
medium and cells were suspended. Then 10 μL suspension was taken and put onto 
the hemocytometer, cells were counted as the number of cells per 25 square (1 mm
2
). 
The cell number calculation is as follows:  
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10
4
 (constant number) x Amount of counted cell = Cell number/ml  
Total cell number = Cell number/ mL x Total volume of cells (10 ml)  
2.2.6.3 Cell passage  
After cells were lifted and cell density was determined (80% and above), cells were 
put into the centrifuge tubes and centrifuged 1000 rpm for 3 min. The supernatant 
was discarded and pellet was resuspended with culture medium and 1x10
6
 cells were 
transferred to clean culture flask. 
2.2.6.4 Cell freezing 
After cell passage, cells resuspended in medium were transferred to freezing tube 
with freezing medium for future experiments. Estimated cell number per freezing 
tube was 1x10
6
 cell/mL. 
2.2.7 Transient transfection of MCF-7 cells with Bag-1 plasmid 
Transfection is the process to introduce a foreign DNA into the cell. In this study 
DNA was inserted into MCF-7 cells by lipofection. The synthetic cationic lipids that 
can form liposome are incubated with DNA. These liposomes interact with DNA 
through electrostatic interaction between the negatively charged nucleic acid and 
positively charged head group of synthetic lipid, and fuse with cultured cells. The 
liposome complex neutralizes the negatively charge of the nucleic acids, allowing 
association of the complex with the negative charged cell membrane. Entry of the 
liposome complex into the cell may occur by the processes of endocytosis or fusion 
with plasma membrane via the lipid moieties of the liposome. After cells were 
detached and cell number was calculated, 50.000 cells per well were seeded on 24 
well tissue culture plate 2 day before the transfection, so that the cells were 
approximately 80% confluent on the day of transfection. 1 μg of plasmid DNAs are 
diluted in 200 μL serum-free DMEM (1X) and vortexed and quickly spun. Then, 3 µl 
FuGENE® HD Transfection Reagent (for western blot experiments) or 3 µl 
Transpass Transfection Reagent (for cellular experiments)  was added to and 
vortexed and quickly spun for the formation of transfection complex, and later 
incubated for 15 min at room temperature. Transfection complex was shared to the 
wells with equal amounts, and cells were returned to the 37
o
C, 5% CO2 incubator for 
24 h or 48 h before analysis. 
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2.2.8 siRNA transfection 
Santa Cruz human Bag-1 siRNA was used for the silencing of Bag-1 gene. 
Lyophilized siRNA stock was 330 μL RNAse-free water and diluted as a working 
solution for transfection. 40 pmol dilution of siRNA was optimum for MCF-7 cells 
for silencing. Opti-MEM® Reduced Serum Medium was used for dilution of siRNA 
to form transfection comlex. Since Opti-MEM® Reduced Serum Medium is an 
improved Minimal Essential Medium (MEM) that allows for a reduction of Fetal 
Bovine Serum supplementation by at least 50% with no change to growth rate or 
morphology and it is also recommended for use with cationic lipid transfection 
reagents, such as Lipofectamine reagent, it was chosen as a transfection medium. 
Lipofectamine 2000 of Invitrogen was used as lipid agent to increase permeability of 
the cell membrane, and the manufacture’s instructions were followed. 
2.2.9 Cell imaging 
Visualization of MCF-7 cells is important for determination of cell morphology and 
alterations after Bag-1 plasmid transfection. 6x10
5
 cells were seeded into each well 
of 6-well plate. One day later cells were tansfected with the Bag-1 plasmid. Control 
and Bag-1 plasmid transfected cells were imaged using Olympus DC71 inverted 
microscope. 
2.2.10 Fluorescent staining 
Four different flurescent dyes were used as apoptotic markers for the determination 
of apoptotic cells under flurescent microscope.  
Propidium iodide (PI) binds to DNA by intercalating between the bases with little or 
no sequence preference and with a stoichiometry of one dye per 4–5 base pairs of 
DNA. Once the dye is bound to nucleic acids, its fluorescence is enhanced 20- to 30-
fold, the fluorescence excitation maximum is shifted ~30–40 nm to the red and the 
fluorescence emission maximum is shifted ~15 nm to the blue. Since PI is membrane 
impermeant and genarally excluded from viable cells, it is suitible for the 
identification of dead cells. 
Acridine orange is a cell-permeant nucleic acid binding dye that emits green 
fluorescence when bound to dsDNA and red fluorescence when bound to ssDNA or 
RNA. By means of this unique property, acridine orange can be used for the 
detection of shreded DNA which is one of the indicators of apoptosis. After acridine 
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orange staining, healty cells gets dyed green while apoptotic cells are observed 
redish-orange. 
The blue-fluorescent DAPI nucleic acid stain preferentially stains dsDNA; it appears 
to associate with AT clusters in the minor groove. Binding of DAPI to dsDNA 
produces a ~20-fold fluorescence enhancement, apparently due to the displacement 
of water molecules from both DAPI and the minor groove. DAPI dyes both healty 
and apoptotic cells to blue but the brightness of apoptotic cells are higher due to the 
nuclear fragmentation. 
DiOC6 is a fluorescent dye used for the staining of a cell's endoplasmic reticulum, 
vesicle membranes and mitochondria. Binding to these structures occurs via the dye's 
hydrophilic groups. DiOC6 can be used to label living cells, however they are quickly 
damaged due to photodynamic toxicity, so cells stained with this dye can only be 
exposed to light for short periods of time. When exposed to blue light, the dye 
fluoresces green. 
The usage of fluorescent dyes and colours of cells after staining is given in Table 
2.15. 
Table 2.15 : The apoptotic stains used in this study. 
Dye Dilution 
Incubation 
time 
Filter Colour 
Acridine 
orange 
1:2000 5 min Blue 
Alive: Green 
Death: Orange 
Propidium 
iodide 
1:5000 30 min Green 
Alive: Not 
stained 
Death: Red 
DAPI 1:1000 10 min 
Green 
 
Alive: Blue 
Death: Bright 
blue 
DiOC6 1:1000 15 min Blue 
Alive: Green 
Death: Yellow 
2.2.11 Survival Assay (Trypan Blue Dye Exclusion Assay)  
Trypan Blue is a vital dye of which reactivity is based on the fact that the 
chromopore is negatively charged and does not interact with the cell unless the 
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membrane is damaged. According to the time points, cells were counted each day for 
4 days using dye exclusion assay. 0,5x10
5
 cells were seeded in each well of the 6-
well plate one day before transfection. 24, 48, 72 and 96 h after transfection, growth 
medium was removed and cells were washed twice with PBS. Cells were trypsinized 
and gathered by centrifugation. Then, cells were exposed to 0.4% (w/v) Trypan blue 
dye (50µL) and DMEM  (50µL) at 1:1 ratio. Dual-chamber FisherLab 
hemacytometer was filled with 10 µL of cells from trypan blue-DMEM mixture, and 
under a light microscope, non-viable cells were observed as stained while viable cells 
excluded the stain. Stained cells were counted and plotted. 
2.2.12 XTT cell viability assay 
Cell Signaling’s XTT Cell Viability Kit was used for the detection of viable cells 
after different treatments (overexpression and silencing). The XTT Cell Viability 
Assay Kit is a colorimetric assay that detects the cellular metabolic activities. During 
the assay, the yellow tetrazolium salt, XTT, is reduced to a highly colored formazan 
dye by dehydrogenase enzymes in metabolically active cells. This conversion only 
occurs in viable cells and thus, the amount of the formazan produced is proportional 
to viable cells in the sample. The formazan dye formed in the assay is soluble in 
aqueous solution and can be quantified by measuring the absorbance at wavelength 
450 nm using a spectrophotometer. An electron coupling reagent, such as PMS (N-
Methylphenazonium methyl sulfate), can significantly improve the efficiency of 
XTT reduction in cells. 1x10
4
 cells were seeded in each well of 96-well plate one day 
before Bag-1 siRNA and Bag-1 plasmid transfection. Then, 24, 48 and 72 h after 
transfection XTT assay was applied, following the instructions of the manufacturer. 
2.2.13 Immunostaining 
Immunostaining is a biochemical technique used to visualize proteins in the cell. The 
primary antibodies which are specific for the intended protein and secondary 
antibodies which are specific for the IgG heavy and light chains of the primary 
antibody are used. Detection is usually performed by fluorescence. MCF-7 cells 
(2x10
4
) were seeded on poly-L-lysine coated coverslips and transfected with Bag-1 
plasmid DNA. After 48 h transfection, culture medium was removed, and cells were 
washed 2 times with PBS. Cells were fixed in prechilled methanol and incubated 15 
min at -20
o
C, and cells were washed 3 times with PBS. Blocking solution was 
37 
prepared 10% antibody specific serum, 10 mg/mL bovine serum albumin (BSA) and 
PBS, then, cells were blocked with blocking solution for1 h at room temperature. 
Primary antibodies were diluted in PBS (1:200 mouse monoclonal anti-Bag-1, 1:200 
rabbit monoclonal anti-β-actin, 1:200 rabbit polyclonal anti-C-Raf, 1:200 rabbit 
monoclonal anti-B-Raf, 1:200 rabbit monoclonal anti-Bcl-2, 1:200 rabbit polyclonal 
anti-Hsp70, 1:200 rabbit monoclonal anti-Phospho-Akt (Ser473) antibodies). Cells 
were incubated with 300 μL antibody solution overnight at 4oC. Following day 
primary antibodies were removed, and cells were washed 3 times with PBS. Cells 
were blocked with blocking solution 1 h at room temperature. Secondary antibodies 
were diluted with PBS (1:1000 both Alexa Flour® 647 goat anti-mouse, 488 goat 
anti-rabbit Alexa Flour®), and cells were treated with secondary antibody solution 
for 1 h at 37°C in dark. Cells were washed once for 5 min with PBS, then were 
incubated 1:1000 diluted DAPI for 5 min. After washing steps (3 times with PBS) 10 
μL mounting medium was added into slides. Coverslips were put onto object slide 
and fixed by using nail polisher. Samples were visualized and analyzed by using 
Leica TCS SP2 SE Confocal Microscope with appropriate laser beams 
 and photos were taken under 63X magnification. 
2.2.14 Total protein isolation 
Total protein isolation from cells was performed by using ROCHE, cOmplete Lysis-
M Kit EDTA-free. Each well of a 6 well-plate was seeded with 1X10
6
 cells, and 
transfected with Bag-1 plasmid DNAor Bag-1 siRNA. After 48 h transfection, one 
complete-M Mini tablet was dissolved in 1,5 mL ProteoJET™ Mammalian Cell 
Lysis Reagent Reagent to prepare working solution. Culture medium was removed, 
and cells were washed with PBS. Cells were gathered in to microcentrifuge tubes 
using cell scrapper and centrifuged at 13200 rpm for 5 min. 50 μL lysis buffer was 
added to each microcentrifuge tube and incubated for 15 min on ice on an orbital 
shaker. Microcentrifuge tubes were cemtrifuged at 20000 rpm for 15 min., and 
supernatants containing soluable proteins were transfered into clean tubes and stored 
-80°C. 
2.2.15 Phospho-protein isolation 
Phospho-protein isolation from cells was performed by using ROCHE, PhosSTOP; 
Phosphatase Inhibitor Cocktail Tablets supplied in EASYpacks. PhosSTOP provides 
38 
isolating or detecting phosphorylated proteins and benefits the ultimate in 
convenience to protect proteins against phosphatase activity. 1x10
6
 cells were seeded 
each well of 6 well plate and transfected with Bag-1 plasmid DNA or Bag-1 siRNA. 
50 μL 10x PhosStop-Phosphatase Inhibitor Tablets, 50 μL cOmplete, EDTA-free 
Protease Inhibitor Cocktail Tablets and 500 µL ProteoJET™ Mammalian Cell Lysis 
Reagent were mixed, and cell lysis solution was prepared. Then instructions of the 
manufacturer were followed. 
2.2.16 Bradford assay 
The determination of proteins was performed using BIO-RAD’s Quick Start 
Bradford protein assay. The principle of assay is rely on binding of Coommassie 
Brilliant Blue G-250 dye (also known as Bradford dye) to proteins. Under acidic 
conditions, the dye is predominantly in the doubly protonated red cationic form (Amax 
= 470 nm). However, when the dye binds to protein, it is converted to a stable 
unprotonated blue form (Amax = 595 nm). It is this blue protein-dye form that is 
detected at 595 nm in the assay using a spectrophotometer or microplate reader. The 
dye was diluted with distile water at 1:4 ratio. Bovine Serum Albumin Standard Set 
was chosen for microassay (the linear range of these assays for BSA is 1.25-10 
μg/mL). 1X Bradford dye reagent was removed from the 4°C storage, and was 
warmed to ambient temperature. 200 µL of dye was shared each well in the plate, 
and all loading process was duplicated to confirm lineer range of standarts and to get 
more accurate results. 5 µL of BSA standarts were put into dye-loaded wells with the 
concentrations of 0,125; 0,25; 0,5; 0,75; 1; 1,5; 2 mg/mL, respectively. 5 µL of 
proteins of which concentrations were unkown were put into dye-loaded wells, and 
microplate was incubated at room temparature about 5 min. After incubation 
absorbance was measured at 595 nm on plate reader. 
2.2.17 SDS-polyacrylamide gel electrophoresis of proteins (SDS-PAGE) 
Sodium dodecyl sulfate (SDS) polyacrylamide gel electrophoresis is a technique 
widely used to separate proteins according to electrophoretic mobility. In this 
method, tertiary structure of proteins is disrupted by SDS and reducing agents such 
as β-mercaptoethanol. The proteins are separated in gel according to their size. In this 
study, Fluka SDS Preparation Kit is used for preparation both 5% stacking gel and 10 
% separating gel, contents of both were described in Table 2.16 and Table 2.17, 
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respectively. Prepared gels were poured between SDS-glasses and left for 
polymerization. After gel polymerized, samples, that were mixed 6X SDS-loading 
dye and boiled 95°C for 5 min to gain primary structure, were loaded in equal 
concentration into wells. The gel was placed into a tank and was run in a running 
buffer at 25 mA for 2 h. 
Table 2.16 : Content of 5% stacking gel. 
Contents Volume 
Stacking acrylamide 0,25 ml 
Gel buffer 0,75 ml 
dH2O 2 ml 
10% APS 20 μL 
TEMED 2 μL 
Table 2.17 : Content of 10% separating gel. 
Contents Volume 
50% glycerol 2 ml 
Separating acrylamide 1,22 ml 
Gel buffer 2 ml 
dH2O 0,78 ml 
10 % APS 75 μL 
TEMED 7,5 μL 
2.2.18 Western blotting 
Western blot is used to detect specific proteins. After separation of denatured 
proteins according to size by SDS-PAGE, the proteins are transferred to 
nitrocellulose membrane where they are labeled using antibodies specific to the 
target protein. After SDS-PAGE, gel was taken from the tank and stripped off the 
glasses. Transfer of proteins from gel to the membrane was done in two different 
ways: (A) Semidry transfer; nitrocellulose membrane and 2 filter papers were put 
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into towbin electrotransfer buffer for 10 min for equilibration, then protein transfer 
was carried out in semi-dry blotting apparatus for 20 V for 30 min at 4 °C, (B) Trans-
Blot Turbo transfer system; gel was put into Trans-Blot® Turbo Midi Nitrocellulose 
Transfer Packs, then protein transfer was carried out in Trans-Blot® Turbo tranfer 
system at 25 V for 8 min. After transfer, membrane was blocked with a blocking 
solution to prevent non-specific binding to empty regions on the membrane. In other 
words, efficient blocking simply reduces the background. After blocking, the 
membrane was incubated with 1:500 diluted with blocking solution primary 
antibodies, which are listed in Table 2.3, for overnight at 4 °C with gentle shaking. 
Following day, membrane was washed with TBS-T buffer for 5 min 6 times with 
gentle shaking, 1:5000 diluted secondary antibody was prepared in blocking solution, 
and was incubated with secondary antibody for 1 h at room temperature. After 5 
times washing of membrane with PBS-T, 20X LumiGLO® Reagent or 
SuperSignal® West Femto Maximum Sensitivity Substrate was used for the 
detection of proteins according to manufacturer’s instructions. The membrane was 
exposed to X-ray film for a certain time and then developed in Kodak Medical X-ray 
Processor according to manufacturer’s instruction. 
2.2.19 Protein stripping 
Restore Western Blot Stripping Buffer was used to obtain different protein imaging 
from a single membrane. The reason that we chose this product was that since the 
product procedure does not include heating, protein loss due to the heat is prevented. 
Protein stripping was performed following instructions of the manufacturer.  
2.2.20 Co-immunoprecipitation 
Co-immunoprecipitation (CoIP) is a method used for isolation of intact protein 
complexes. In this study CoIP was applied for the investgation of Bag-1 protein’s 
interacting partners in MCF-7 breast cancer cell lines. CoIP works by selecting an 
antibody that targets a known protein that is believed to be in an interaction with a 
large number of proteins. By targeting this known member with an antibody it may 
become possible to pull the entire protein complex out of solution and thereby 
identify unknown members of the complex, in this case unknown interacting 
partners. CoIP was performed for both Bag-1 and C-Raf proteins using monoclonal 
anti-Bag-1 and polyclonal anti-C-Raf antibodies, respectively. Invitrogen’s 
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Dynabeads® Protein G was utilized as magnetic beads, following instructions of the 
manufacturer to attach selected antibodies. Bag-1 proteins bound with Bag-1 
antibodies onto the beads were eluted using 20 μL elution buffer, and the tubes were 
incubated for 10 min at 70 °C in order to dissociate the complex. After dissociation 
of  complex, proteins were mixed with 6X Laemmli buffer and loaded onto SDS gel 
for western blotting. Known and estimated interacting partners (Bcl-2, Hsp70, C-Raf, 
B-Raf, P-Akt) were checked using specific antibodies. Same procedure was 
introduced for immunoprecipitation of C-Raf. 
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3.  RESULTS 
3.1 Identification of Bag-1 isoforms 
Immunodetection of Bag-1 with monoclonal α-Bag-1 antibody revealed three major 
isoforms of Bag-1 (first lane of the Figure 3.1). In second lane of Figure 3.2 MCF-7 
cells were transfected with TAP-tag containing-Bag-1 overexpressing plasmid. Due 
to the alternative translation from N-terminus of Bag-1 mRNA, three major isoforms 
and their TAP-tag (∼19 kDa) containing versions are visible (second lane of the 
Figure 3.1). 
 
Figure 3.1 : Western blot analysis of TAP-tag containing Bag-1L transiently 
transfected MCF-7 cells. Immunodetection of Bag-1 reveals multiple 
bands due to the alternative translation of Bag-1 mRNA, three major 
isoforms and their 17 kDa TAP-tagged versions are visible (second lane 
of the Figure 3.1). 
3.2. Imaging of cell morphology 
Cell imaging was done to observe cell morphology at indicated time points. 6x10
5
 
MCF-7 cells were seeded into 6-well plate, and cell pictures were taken with light 
microscopy. Wild type cells can be seen at the left side of Figure 3.2. MCF-7 cells 
were transfected with Bag-1 overexpressing plasmid, and cell pictures were taken 
(right side of Figure 3.2). Three different magnification was chosen to visualize cell 
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morphology. Results show that podia formation is clearer, and podia number is 
increased after 48 h from Bag-1 overexpression. Since MCF-7 cells are adherent 
cancer cells, these pictures might indicate that Bag-1 overexpression could be 
important for cell to cell communication and adhesion.  
The black dots at the right side of Figure 3.2 are caused by transient transfection. 
These are lipid particles arised due to the application of lipid-based transfection 
reagent.  
 
Figure 3.2 : Light microscopy images of cell morphologies. After 48 h from 
transfection with Bag-1 overexpressing plasmid podia number of cells 
were increased, and podia formation was become clearer. 
3.3. Overexpression of Bag-1 promotes cell survival 
3.3.1. MCF-7 cell viability alterations occur by Bag-1 amount change 
To address the potential role of Bag-1 in control of cell survival and cell viability in 
MCF-7 breast cancer cells, we examined the expression and subcellular localization 
of Bag-1.  
First, Bag-1 expression levels were detected with α-Bag-1 antibody. β-actin was used 
for normalization. Bag-1 overexpression and Bag-1 silencing were confirmed (Figure 
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3.3 -A) and densitometric analysis were reported with the usage of  computer 
softwares (Figure 3.3 -B). 
 
 
Figure 3.3 : Western blotting results of wild type, Bag-1 overexpressed and Bag-1 
siRNA transfected MCF-7 cells. Bag-1 isoforms and alterations of 
expression levels of  isoforms detected with α-Bag-1 antibody (A). 
Relative expression levels depend on desitometry of bands (B). 
After verification of Bag-1 overexpression and silencing, we examined the level of 
change in cell viability upon Bag-1 alterations by cell survival (trypan blue dye 
exclusion assay) and XTT cell viability assays (Figure 3.4). 
Wild type, Bag-1 overexpressed and Bag-1 siRNA treated MCF-7 cells were counted 
at indicated time points. Cells were collected, and trypan blue dye exclusion assay 
was performed (Figure 3.4-A). 10 µL of trypan blue/cell culture (1:1 ratio) mix was 
transfered into hemocytometer, and alive cells that dyed with trypan blue were 
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counted. Trypan blue assay results showed that Bag-1 overexpressed MCF-7 cell 
numbers are significantly higher than wild type (blue line) cells at the end of the 48 h 
and 72 h transfection (red line). On the other hand Bag-1 siRNA transfected cell 
numbers (green line) are fewer than wild type (Figure 3.4-A). This result might be an 
indication of Bag-1 silencing effect promotes apoptosis while with Bag-1 
overexpression cell survival is modelated. 
To ascertain percentage of viable cells after Bag-1 siRNA and Bag-1 overexpressing 
plasmid, we applied XTT cell viability assay (Figure 3.4-B). During the assay, the 
yellow tetrazolium salt, XTT, is reduced to a highly colored formazan dye by 
dehydrogenase enzymes in metabolically active cells. Thus, this conversion only 
occurs in viable cells. XTT cell viability assay showed that 48 h and 72 h Bag-1 
overexpressed cells had the highest percentage of viability. However, in 48 h Bag-1 
siRNA transfected cells, viability was decreased (Figure 3.4-B). 
 
Figure 3.4 : MCF-7 cell viability gets altered due to the changes of Bag-1 
expression level. Cell survival (trypan blue dye exclusion) assay 
revealed that viable cell numbers increased by Bag-1 overexpression 
(A). Viable cell numbers was lower in comparison to wild type MCF-7 
cells (A). XTT cell viability test also revealed similar results (B). Bag-1 
overexpression elevated percentage of viable MCF-7 cells while Bag-1 
down regulation decreases the percentage of viable cells (B) in MCF-7 
culture. 
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3.3.2 Analysis of Cell Survival Proteins Showed That Bag-1 Overexpression 
Promotes Cell Survival 
3.3.2.1 In parallel to Bag-1 overexpression, B-Raf and C-Raf protein expressions 
are enhanced 
B-Raf and C-Raf, they are most important members of Ser/Thr kinase Raf protein 
family. Both are involved in Raf-MEK-Erk pathway, which is mitogen-activated 
protein kinase cascade that controls many molecular mechanisms such as 
proliferation, differentiation and cell survival. Bag-1 interactions with C-Raf and B-
Raf were previously suggested, therefore we first examined C-Raf/B-Raf signaling 
pathway that might potentially explain the route of Bag-1 involvement in cell 
survival. We performed western blot analysis with total proteins derived from wild 
type, Bag-1 overexpressed and Bag-1 siRNA transfected MCF-7 cells (Figure 3.5). 
Western blotting showed that overexpression of Bag-1 highly increases both B-Raf 
(Figure 3.5-A) and C-Raf (Figure 3.5-C) expression. Since overexpression of Bag-1 
increased the expression levels of C-Raf and B-Raf, we checked the phosphorylation 
states of these. Western blot results showed that activatory site of C-Raf “Ser338 
residue” (Figure 3.5-D) phosphorylation and phospho-C-Raf Ser289/296/301 (Figure 
3.5-E) expressions were higher with Bag-1 overexpression. In addition, we observed 
that phospho-B-Raf Ser445 (Figure 3.5-B) level was elevated with Bag-1 
overexpression. Akt kinase phosphorylation is essential for the prevention of cell 
death, and the initiation of survival signaling by means of interaction with B-Raf. 
Hence, we noticed that phospho-Akt at Ser473 (Figure 3.5-F) level was also 
increased with Bag-1 overexpression. Morever, we checked Hsp70, which is another 
main interacting partner of Bag-1, and western blotting revealed that Hsp70 
expression elevated through Bag-1 overexpression and down regulated with Bag-1 
silencing (Figure 3.5-G). All western blotting results were normalized with β-actin, 
and relative expression levels were reported via densitometric analyses (Figure 3.5-
H). 
 3.3.2.2 Bag-1 overexpression stimulates MEK-Erk pathway 
After confirmation of that Bag-1 promotes sell survival proteins, we decided to 
investigate the alterations on the downstream of the MAPK pathway. We applied 
48 
 
 
Figure 3.5 : Western blotting revealed that overexpression of Bag-1 upregulates B-
Raf and C-Raf. Two of the known interacting partners of Bag-1 and 
also important players of cell survival signaling pathway, B-Raf and C-
Raf expression was increased by Bag-1 overexpressed MCF-7 cells (A 
and C). Phosphorylation levels of survival pathway proteins were also 
examined. Phospho-B-Raf Ser445, phospho-C-Raf Ser338, phospho-C-
Raf Ser289/291/301 (B,D and E). Expressions of phospho-Akt Ser473 
and Hsp70, other known interacting partners of Bag-1 during cell 
survival, were checked, as well (F and G). Expression levels of 
indicated proteins were elevated with Bag-1 overexpression (H). 
western blot analysis for Erk and MEK which are next proteins in MAPK dual 
cascade, and we observed that  while Erk expression level did not change 
significantly, MEK expression level got higher with Bag-1 overexpression. We 
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noticed that phospho-MEK Ser221 expression level dramatically rose after Bag-1 
overexpression (Figure 3.6).  
 
 
Figure 3.6 : Bag-1 overexpression modulates the activation the kinases in the  
downstream of MAPK pathway. Downstream players of MAP kinase 
dual cascade MEK1/2 and its phosphorylated form phospho-MEK1/2 
Ser221 expressions changed in parallel with Bag-1 overexpression (B 
and C). However, we were not able to observe significant alteration in 
Erk1/2 expression level (A). All results were normalized with β-actin, 
and relative expression levels were calculated (D). 
3.4. Identifying the interaction partners of Bag-1 during cell survival 
Bag-1 interacts a group of proteins to form a complex to inhibit apoptosis, and direct 
cells to survival. We performed co-immunoprecipitation to identify interacting 
partners of Bag-1 during cell survival. We used magnetic beads which were loaded 
with α-Bag-1 antibody to pull down protein complex from total protein lysate. We 
first confirmed that Bag-1 immunoprecipitation was successful (Figure 3.7-A). Then, 
we checked interacting partners of Bag-1 with specific antibodies using western 
blotting (Figure 3.7). Co-immunoprecipitation revealed that Bag-1 interacts with B-
Raf, Bcl-2, Phospho-Akt, Hsp70, and C-Raf (Figure 3.7- B to F). We used β-actin 
and A-Raf as the negative controls, as expected we did not observe any bands for 
these proteins (Figure 3.7- G and H). 
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A study about survival of neuronal cells revealed that Bag-1, B-Raf, Bcl-2, Phospho-
Akt, and Hsp70 form a complex to provide Bad phosphorylation at Ser136. 
Phosphorylated Bad interacts with 14-3-3 scaffold protein, which leads cell to 
survival. Suprisingly, we discovered that C-Raf was also involved in this complex in 
MCF-7 breast cancer cells (Figure 3.7-F). Since MCF-7 cells are cancerous, C-Raf 
involvement with the detected complex may shed light to one of the paths of survival 
in breast cancer cells. It may indicate that Bag-1 overexpression in cancer cells 
stimulates C-Raf to direct cells to survival.  
 
Figure 3.7 : Co-immunoprecipitation with α-Bag-1 antibody revealed the interacting 
partners of Bag-1 in the cell survival pathway. Verification of 
immunoprecipitation was done by western blotting . Results showed 
that Bag-1, B-Raf, Bcl-2, phosphorylated Akt, Hsp70, and C-Raf exist 
together (A, B, C, D, E, and F, respectively). β-actin and A-Raf was 
used as the negative controls, as expected any bands were observed for 
these proteins (G and H). 
To verify the involvement of C-Raf in Bag-1-related cell survival complex, we 
applied co-immunoprecipitation for C-Raf. α-C-Raf antibody was used for the 
precipitation of C-Raf, and western blotting was performed to investigate indicated 
members of the survival complex (Figure 3.8). We confirmed that C-Raf exists in the 
complex along with B-Raf, Bag-1, Phospho-Akt, Bcl-2, and Hsp-70 (Figure 3.8-A to 
F). We used β-actin and A-Raf as the negative controls, as expected we did not 
observe any bands for these proteins (Figure 3.8-G and H). 
51 
 
Figure 3.8 : Co-immunoprecipitation for α-C-Raf antibody confirmed that C-Raf’s 
involvement in Bag-1-related survival complex. Western blotting for C-
Raf, B-Raf, Bag-1, phosphorylated Akt, Bcl-2, and Hsp70 after C-Raf 
precipitation proved the co-existance of these proteins (A, B, C, D, E, 
and F, respectively). β-actin and A-Raf was used as the negative 
controls, as expected any bands were observed for these proteins (G and 
H). 
3.5. Co-localisation of Bag-1 and its interacting partners 
After detecting the co-existence of Bag-1 and its interacting partners, we used 
immunocytochemistry to display their co-localisation in the subcellular environment. 
We did double staining to Bag-1 overexpressed MCF-7 cells with Alexa Flour 647 
goat anti-mouse for Bag-1 and Alexa Flour 488 goat anti-rabbit for the interacting 
partners. β-actin was used both as the negative control and reference protein. Since 
β-actin is a structural protein, it was useful to demonstrate the cell morphology 
(Figure 3.9-A). Co-localisation of Bag-1 with B-Raf, Bcl-2, Hsp70 and Phospho-Akt 
in cytoplasm can be seen at Figure 3.9- B, D, E and F, respectively. We also 
observed that C-Raf co-localisation with Bag-1 in the cytoplasm, but also C-raf was 
observed in the nucleus, revealing its secondary downstream role for the control of 
transcription in nucleus (Figure 3.9-C). 
3.6. Alterations of Pro- and Anti-Apoptotic Protein Levels 
As an anti-apoptotic protein Bag-1,it can get involved in the regulation of apoptosis. 
Thus, to investigate molecular mechanism of apoptosis in case of altered Bag-1 
levels, we performed western blot analysis to determine expression levels of 
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Figure 3.9 : Subcellular co-localization of Bag-1 and its interacting partners in the 
survival complex. Since DAPI stains nucleus, it was used for detection 
of cells (Blue). Bag-1 dyed with Alexa Flour 647 goat anti-mouse 
(Green) while other indicated proteins dyed with Alexa Flour 488 goat 
anti-rabbit (Red). β-actin was utilized to demonstrate separate 
localisation with Bag-1 (A). Bag-1 co-localise with B-Raf, Bcl-2, 
Hsp70 and Phospho-Akt in cytosol (B, D, E, and F, respectively). We 
observed C-Raf co-localisation with Bag-1 in nucleus, but we also 
observed that C-Raf exists nucleus, independent from Bag-1 (C). 
proteins and other anti-apoptotic proteins (Figure 3.10). 
Bad and Bax are two members of Bcl-2 family. They both act as pro-apoptotic 
agents, but while Bad binds and regulates anti-apoptotic Bcl-2 proteins to promote 
apoptosis, Bax directly binds and inhibits Bcl-2 and other anti-apoptotic proteins. 
Bcl-2 is the most known anti-apoptotic protein which inhibits apoptosis, and 
promotes cell survival. When we altered the expression of Bag-1 protein, we did not 
observe any significant change on the Bad expression (Figure 3.10-A). However, we 
observed an increase on Bax expression with Bag-1 siRNA transfection, and Bax 
expression was decreased with Bag-1 overexpression (Figure 3.10-C). Bcl-2 
expression level change was parallel to the Bag-1 expression level. There was an 
increase with Bag-1 overexpression, and a decrease with Bag-1 silencing (Figure 
3.10-B). Ratio of pro-/anti-apoptotic proteins on mitochondrial membrane is used as 
a marker for apoptosis in cells. It is known that  Bax/Bcl-2 ratio determines the 
susceptibility to apoptosis in melanoma cells by regulating mitochondrial function. 
Hence, we calculated the Bax/Bcl-2 ratio after both for Bag-1 overexpression and 
Bag-1 siRNA treatment of MCF-7 breast cancer cells. We could observe that 
Bax/Bcl-2 ratio decreased in Bag-1 overexpressed MCF-7 cells while dramatically 
increased in 48 h Bag-1 siRNA transfected MCF-7 cells. These results confirmed 
that Bag-1 downregulation increases sensitivity to apoptosis in MCF-7 cells (Figure 
3.10-F) 
We also checked Bim protein expression, which is an indicator of late apoptosis in 
certain carcinoma such as colon cancer and neuroblastoma. However our, results 
showed that expression of Bim isoforms was not altered by Bag-1 expression change 
(Figure 3.10-D). 
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Figure 3.10 : Expressions of pro- and anti-apoptotic proteins on mitochondral 
membrane were altered by Bag-1 expression variations. Western blot 
analysis revealed that expression of pro-apoptotic proteins; Bad and 
Bim did not show any change by Bag-1 alterations (A and D). 
However expression of another important pro-apoptic, Bax, were 
upregulated by Bag-1 overexpression (C). Bcl-2, one of the most 
known anti-apoptotic proteins, expression change was parallel to the 
Bag-1 expression level (B). All results were normalized with β-actin, 
and densitometries of bands were calculated (E). Bax/Bcl-2 ratio was 
calculated to determine pro- and anti-apoptotic protein abundance on 
mithocondria (F). 
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3.7. Silencing of bag-1 gene increases cell death in MCF-7 breast cancer cell line 
To show the effect of Bag-1 protein level change on cell death, various fuorescent 
dyes were used (Figure 3.11).  
Propidium iodide (PI) is an impermeant dye which stains dead cells and gets 
generally excluded from viable cells. PI intercalates into double stranded nucleic 
acids. Figure 3.11-A shows the PI-stained MCF-7 cells. First and second columnn 
were for wild type and Bag-1 overexpressed MCF-7 cells, where no PI staing were 
observed. With the transfection of Bag-1 siRNA to MCF-7 cells a significant 
increase in the amount of death cells were seen (third and fourth column of Figure 
3.11-A). 
Acridine orange is a cell-permeant nucleic acid binding dye which emits green 
fluorescence when bound to dsDNA and red fluorescence when bound to ssDNA or 
RNA. Wild type and Bag-1 overexpressed cells were dyed green because of their 
healty DNA. Since DNA is shreaded in apoptotic or death prone cells, they are dyed 
orange-red which can be seen in Bag-1 siRNA transfected cells at indicated time 
points (Figure 3.11-B). 
DAPI is a nucleic acid stain that dye both healty and apoptotic cells. DAPI dyes 
healty cells blue (first and second column of Figure 3.11-C). However apoptotic cells 
were observed as bright dots because of the degradation of chromosomal DNA (third 
and fourth column of Figure 3.11-C). 
DiOC6 dyes endoplasmic reticulum of cells, vesicle membranes and mitochondria. 
Since healty cells have intact organelle membrane compartmentalisation, DiOC6 
stains healty cells green (first and second column of Figure 3.11-D). Apoptotic cells 
seem to be blurry-yellow because of the loss of membrane integrity of the organelles 
(third and fourth row of Figure 3.11-D). 
3.8. Phosphorylation of Bad is upregulated by Bag-1 overexpression 
Effects of Bag-1 overexpression on survival pathway proteins were demonstrated in 
Figure 3.5. We showed that increased amount of Bag-1 promotes cell survival by 
upregulating the expression levels of survival proteins such as C-Raf and B-Raf. To 
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Figure 3.11 : Fluorescent staining showed that down regulation of Bag-1 elevated 
death cell population in MCF-7 culture. Propidium iodide, acridine 
orange, DAPI, and DiOC6 stainings revealed that silencing Bag-1 
increases cell death after 48 h Bag-1 siRNA transfection (A, B, C, and 
D, respectively). 
investigate downstream mechanism of cell survival after Bag-1 overexpression, we 
investigated phosphorylation level of Bad protein. Although we did not see any 
significant change on Bad expression (Figure 3.12-A), we observed that 
phosphorylation level of Bad at Ser136 is dramatically upregulated by Bag-1 
overexpression (Figure 3.12-B). Phosphorylation of Bad may lead to the prevention 
of cell death by a mechanism which includes selective association of the 
phosphorylated form of Bad with 14-3-3 scaffold protein isoforms. The interaction of 
Bad/14-3-3 occurs when Bad gets phosphorylated at serine 136, and triggered 
association of Bad with 14-3-3 appears to prevent Bad interactions with Bcl-XL and 
Bcl-2. Thus, interruption of Bad interactions with Bcl-XL or Bcl-2 inhibits pro-
apoptotic oligomerization on mitochondrial membrane, which prevents cell death. 
Our results revealed that Bag-1 overexpression increases the phosphorylation level of 
Bad at Ser136, suggesting a route for cell survival through Bad/14-3-3 association. 
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Figure 3.12 : Western blotting results showed that phosphorylation level of Bad at 
Ser 136 increases by Bag-1 overexpression. There was not any 
significant change in Bad expression by altered Bag-1 level (A). 
However, phoshorylation of Bad at Ser136 was significantly enhanced 
by the overexpression of Bag-1 (B). 
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4.  DISCUSSION 
Bag-1 (Bcl-2-associated athanogene) is an anti-apoptotic protein which involves a 
great number of molecular mechanisms such as ubiquitinilation, transcription, 
apoptotisis, cell survival, cell motility, proliferation, differantiation and 
tumorigenesis by means of its interactions with other proteins. Bag-1 protein has four 
major isoforms that are resulted from alternative translation; Bag-1L, Bag-1M, Bag-
1S, and Bag-1 (Figure 3.1), and these isoforms have different impacts on heat shock 
protein function, ubiqutinilation machinery and different transcriptional activities. 
The subcellular localizations of Bag-1 isoforms differs between the isoforms; Bag-1S 
is located in cytosol while Bag-1L exists in the nucleus because of its nuclear 
localization signal. Bag-1M can usually be found in cytosol, but since it carries a part 
of the nuclear localization signal, it can be seen in the nucleus rarely (Sharp et al., 
2004). Bag-1 is highly expressed in a variety of cancer types. The balance between 
apoptosis and cancer in the cell may be regulated by Bag-1 and its accompanying 
partners. Since Bag-1 is found near mitochondria and it has isoforms in both nucleus 
and cytosol, it can affect three central compartments of cells. Although it is known 
that Bag-1 interacts with Bcl-2 to inhibit apoptosis, Bag-1’s role or molecular 
mechanism is not clear yet during the prevention of apoptosis or promotion of cell 
survival. However, it is important to consider Bag-1 as a prognostic marker or a 
therapeutic target in cancer (Townsend et al., 2003). 
As it is shown in Figure 3.3, we studied altered levels of Bag-1 (overexpressed or 
silenced) to investigate effects of Bag-1 expression in Bag-1 involved molecular 
mechanisms. Preliminary data showed that overexpression of Bag-1 can be used as 
prognostic factor in several types of carcinomas (Tang et al., 1999). We 
demonstrated that forced-overexpression of Bag-1 increase resistance to cell death 
and promotes cell survival as shown with the trypan blue dye exclusion assay (Figure 
3.4-A) and XTT cell proliferation assay (Figure 3.4-B).  
Even though Bag-1 originally had been identified as a Bcl-2-interacting protein that 
potentiates its survival promoting activity, Bag-1 specifically interacts with C-Raf 
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and with B-Raf, but not with A-Raf. Binding of C-Raf to Bag-1 stimulates its kinase 
activity, and produces signals for cellular growth and differentiation. Hence it was 
hypothesized that Raf kinases which were activated by a Bag-1-dependent 
mechanism, acts as effector kinase of Bcl-2 phosphorylating targets such as Bad 
(Wang et al., 1996). We demonstrated that Raf kinases’ protein levels, B-Raf and C-
Raf, increased in Bag-1 overexpressed cells (Figure 3.5-A and C, respectively). Since 
phosphorylation stimulates the activities of Raf kinases and other survival pathway 
proteins, we checked their expressions via western blotting. We displayed that C-Raf 
phosphorylation at Serine 338 and Serine 289/296/301, which are activatory sites of 
C-Raf, residues increased in parallel with Bag-1 overexpression (Figure 3.5- D and 
E, respectively). Interestingly, we found that B-Raf phosphorylation at Serine 445 
increases with Bag-1 overexpression as well (Figure 3.5-B). We also confirmed that 
expression of Hsp70 and phosphorylation levels of Akt at Serine 473 residue 
upregulated with Bag-1 overexpression (Figure 3.5-F and G, respectively). It is 
known that Bag-1 directly interacts with C-Raf to promote proliferation and cell 
survival (Song et al., 2001), but Götz et al. reported that activation of the MAPK 
pathway and FKHR phosphorylation is normal in bag-/- lack mice brain cells 
suggesting Bag-1 is not necessary for the activity of Raf kinases and Akt. However 
we investigate the downstream signaling pathway stimulated by C-Raf, and our 
results indicate that Erk1/2, MEK1/2, and phospho-MEK1/2 at Serine 221 expression 
levels elevated in parallel with increased C-Raf expression in Bag-1 overexpresssed 
MCF-7 cells (Figure 3.6). 
It was denoted that expression of Bag-1 causes changes in MCF-10A cells 
(immortalized mammary ephitelial cells) grown in 3D cultures, namely a decrease in 
apoptotic cell number and prevention of apoptotic morphology. These effects are 
mediumted through the activation of the serine/threonine kinase C-Raf, with 
evidence of a direct interaction of Bag-1, then subsequent activation of a downstream 
signaling cascade by means of phosphorylation of MEK1/2 and Erk1/2 (Anderson et 
al., 2010). 
In a study with neuronal cells, it was demonstrated that Akt, B-Raf, Bcl-2 and Hsp70 
form a complex including Bag-1, which plays a crucial role on phosphorylation of 
Bad at Serine 136 residue, and leads cell to survival (Frabel et al., 2007). In light of 
our results and Anderson’s studies, we thought that C-Raf might be involved in the 
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survival complex in cancer cells. To identify Bag-1 interacting partners during cell 
survival we performed co-immunoprecipitation with α-Bag-1 antibody and its 
interacting partners in survival complex. We precipitated Bag-1, then checked other 
proteins with western blotting using specific antibodies. The results presented that 
Bag-1 co-exists with B-Raf, phospho-Akt, Bcl-2, Hsp70 and C-Raf (Figure 3.7). We 
also did immunoprecipitation for α-C-Raf antibody to verify our findings. Western 
blot analysis for C-Raf precipitated proteins confirmed the co-existence of Bag-1, 
Hsp70, phospho-Akt, Bcl-2, B-Raf and C-Raf (Figure 3.8). Next step for the 
investigation of C-Raf as a part of survival complex was immunocytochemistry. 
Immunocytochemistry is suitable to show subcellular localisation of Bag-1 and its 
interacting partners by double staining. We observed that Bag-1 co-localise with 
phospho-Akt, Bcl-2, Hsp70, B-Raf and C-Raf in cytoplasm. However, we noticed 
that Bag-1 co-localise with C-Raf in nucleus, as well (Figure 3.9). 
Since Bag-1 collaborates with Bcl-2, and promotes its anti-apoptotic function 
(Takayama et al., 1995), we wondered how Bag-1 effects other members of Bcl-2 
family. Our results from western blot analysis confirmed that elevated expression of 
Bag-1 via forced overexpression increases Bcl-2 expression paralelly, and silencing 
Bag-1 decreases Bcl-2 expression in MCF-7 cells (Figure 3.10-B). We applied 
western blotting for pro-apoptotic agents of Bcl-2 family proteins including Bad, Bax 
and Bim. Bad is a BH3-only protein having conserved BH3 domain that can bind and 
regulate the anti-apoptotic Bcl-2 proteins to promote apoptosis while Bax directly 
binds and inhibits the Bcl2 and other anti-apoptotic family memebers (Youle et al, 
2008). Our results for Bad showed any significant alteration on Bad expression either 
with Bag-1 overexpression or Bag-1 downregulation. However Bax expression 
increased in Bag-1 overexpressed MCF-7 cells, and elevated in 48 h Bag-1 siRNA 
treated MCF-7 cells (Figure 3.10-C). A study on melenoma cells showed that low 
Bax/Bcl-2 ratio was characteristic for death resistant cells and a high Bax/Bcl-2 ratio 
was characteristic for sensitive cells. Furthermore, they reported that Bcl-2 
overexpression abolished apoptosis triggered by apoptotic stimuli like 
chemotherapeutic agents, confirming the importance of the Bax/Bcl-2 ratio as a 
rheostat that determines the susceptibility to apoptosis in melanoma cells by 
regulating mitochondrial function (Raisova et al, 2001). We calculated the Bax/Bcl-2 
ratio after both for Bag-1 overexpression and Bag-1 siRNA treatment. We could 
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observe that Bax/Bcl-2 ratio decreased in Bag-1 overexpressed MCF-7 cells while 
dramatically increased in 48 h Bag-1 siRNA transfedted MCF-7 cells. These result 
confirmed that Bag-1 downregulation increases sensitivity to apoptosis in MCF-7 
cells (Figure 3.10-F). It was noted in the paper by Anderson et al. (2010) that Bim 
expression increases in Bag-1 silenced MCF-10A cell line (also defined as normal 
cells). Nevertheless, our findings for Bim expression did not show any significant 
change in MCF-7 cells (Figure 3.10-D). 
It was shown that forced overexpresssion of Bag-1 p50 (Bag-1L), p46 (Bag-1M), and 
p33 (Bag-1S) led to increased resistance to apoptosis (Chen et al., 2002).  Also in a 
study on Hela cells revealed that a reduction of Bag-1 by antisense cDNA led to the 
sensitization to apoptosis when induced by several chemotheropeutic inducers such 
as staurosporine, paclitaxel, ATRA, and 4-HPR (Xiong et al., 2003). Furthermore, it 
was reported that decresing Bag-1 expression by means of RNA interference method 
incresed sensitivity to apoptosis (Takashi et al., 2003). To demonstrate effects of 
silenced Bag-1 we performed fluorescent staining using apoptotic markers including 
acridine orange, propidium iodide, DAPI, and DiOC6. Fluorescent stainings showed 
that apoptotic cell numbers increased in Bag-1 siRNA transfected MCF-7 cells 
(Figure 3.11). Bim expression can be affected through multiple signaling routes. 
Since our results showed that Bag-1 overexpression increases expression levels of 
survival pathway proteins we would like to check phosphorylation levels of Bad, 
which prevent cell death and lead cells to survive. Altough expression of Bad, itself, 
did not show any significant changes in MCF-7 cells, our results diplayed that 
phosphorylated Bad at Serine 136 residue expression was significantly elevated in 
Bag-1 overexpressed MCF-7 cells (Figure 3.12). Phosphorylation of Bad mostly 
provided by Akt, but also B-Raf and C-Raf which are important kinases for neuronal 
survival (Wiesse et al., 2001). It was demonstrated that Bag-1, Akt, B-Raf, Bcl-2 and 
Hsp70 form a complex to phosphorylate Bad at Serine 136 residue, and leads cell to 
survival (Frabel et al., 2007). It is shown that Bag-1-related cell survival complex 
prevents Bad/Bcl-2 interaction by phosphorylatig Bad (Frabel et al., 2007). 
Phosphorylated Bad associates with 14-3-3 scaffold protein instead of activating cell 
death mechanism on mithochondria (Frabel et al., 2007). We found that C-Raf 
involves in Bag-1-related survival complex in MCF-7 breast cancer cells, which 
differs from neuronal cells. The reason for this might be that since we are using 
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cancerous cells, cell survival mechanism is triggered by the C-Raf activation in these 
cells. 
In summary, Bag-1 overexpression decreases apoptosis, and promotes cell survival 
in MCF-7 breast cancer cells. During to the process of survival, expression of Raf 
kinases increases, and downstream signaling cascade MEK1/2 and Erk1/2 is become 
active. Bag-1 form a complex with its interacting partners to lead cells to survival. 
Our results suggest that C-Raf is involved in the complex that is formed by Bag-1, B-
Raf, Hsp70, phospho-Akt and Bcl-2 in order to phosphorylate Bad at Serine 136 for 
the prevention of apoptosis. Thus, these results not only present a novel insight into 
deciphering the molecular mechanism of estrogen dependent breast cancer 
development, but also targeting Bag-1 or Bag-1/C-Raf interactions may provide an 
effective new strategy for therapeutic intervention. 
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